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ABSTRACT

Papanicolaou (Pap) Test and Human Papillomavirus (HPV) Test Adherence: Sexual Violence
Victims and Fear of Retraumatization

by
Murielle Sighe

Claremont Graduate University: 2022

Background: To include all vulnerable women population who faced barriers to participating in
preventive cervical cancer screening, the public health community must better understand the
factors that affect their decision for getting Pap and HPV tests. Public health must understand the
sexual violence victims, a subgroup of women who faced the onset of trauma and explore their
adherence to routine screening. This study investigated whether sexual women with a history of
sexual violence (SV), likelihood to get screened for cervical cancer would be impacted given the
fear of suffering from secondary trauma during conventional screening procedures.
Methods: Knowledge of cervical screening tests, and the prevalence of victims who indicated
being afraid of getting flashbacks from past trauma, participation in Pap and HPV test was
estimated using the 2018 BRFSS national survey. Connecticut and New Mexico were datasets
used and major predictors in multivariable logistic regressions analyzing the odds of history of
sexual violence trauma and cervical cancer screening.
Results: SV in lifetime HPV participants are significantly (p<0.001) more likely (AOR = 2.08,
CI = 1.46 – 2.95) to receive HPV test cervical screening compared to participants who did not

report past SV and SV in lifetime Pap women were twice as likely (p-value = 0.036) to
participate in PAP testing (AOR = 2.15, CI = 1.05 – 4.41), whereas SV last 12 month HPV
Women were less likely to have received cervical testing than those not reporting recent SV
(AOR = 0.84, CI = 0.19 – 3.60) and SV last 12-month Pap women were less likely to have
received cervical testing than those not reporting recent SV (AOR = 0.23, CI = (0.04 -1.10).
Conclusions: Notable findings were the difference in the likelihood of participation in either Pap
and HPV test between lifetime SV who were more likely to get screened for cervical cancer, and
last 12 month SV seemingly reported less likelihood participation in cervical screening.
Subsequent studies may elucidate why the difference in these patterns was observed and indicate
which other factors might effectively-being considered impacting screening decision making and
which ones are not. Understanding SV fear of retraumatization and insightful indicators can help
practitioners to improve participation in cervical screening toward knowledge gaps and their
causes.
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CHAPTER 1. INTRODUCTION

Background of Study
The primary cause of cervical cancer is the sexually transmitted human Papillomavirus
(HPV), the most common viral infection of the reproductive tract. The American Cancer Society’s
estimates in the U.S. for 2022: About 14,100 new cases of cervical cancer will be diagnosed &
4,280 women will die from it (American Cancer Society, 2022). When caught early, cervical
cancer is very treatable. In 2018, the US Preventive Services Task Force (USPSTF) recommended
screening for cervical cancer every three years with cervical cytology (Pap test) alone in women
aged 21 to 29 years. For women aged 30 to 65 years, the USPSTF recommended screening every
three years with cervical cytology alone, every five years with HPV testing alone, or in
combination every five years (US Preventive Services Task Force, 2018). However, in 2021, the
National Cancer Institute (NCI) put in place the most recent recommended screening guidelines
for cervical cancer: age group between 21 to 24 are not recommended to get screening compared
to 2018, when they were required to get Pap test every 3 years (NCI Staff, 2021). Under the new
guidelines, every 5 years with HPV test alone in women aged 25 to 29 years is preferred, but
HPV/Pap co-test every 5 years is acceptable, and Pap test every 3 years is also acceptable, when
in 2018 Pap test was required every 3 years (NCI Staff, 2021). For women aged 30 to 65 years,
the NCI states screening every five years with HPV alone is preferred, or in combination with the
Pap test is acceptable, but Pap test every 3 years is also acceptable, when in 2018, PAP test was
required every 3 years (NCI Staff, 2021). For the last age range, 65 and older, the NCI states that
no screening is necessary, if a series of prior tests were normal. There is more interest now in
examining people who had an abnormal screening test result at an older age to see if they require
more years of screening or more frequent screening (US Preventive Services Task Force, 2018;
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NCI Staff, 2021).
Both the Pap and HPV tests consist of a doctor using a speculum to widen the vagina,
examine the cervix, and collect a few cells from the cervix. Some women face barriers that prevent
them from seeking preventive screening (Watson-Johnson, Townsend, Basile, & Richardson,
2012; Farid, 2019; Chivers-Wilson, 2006). One of these barriers is the fear of retraumatizationwhich is a conscious or unconscious reminder of past trauma that results in a re-experiencing of
the initial traumatic event (Farid, 2019). It may be triggered by a situation, an attitude or
expression, or a specific environment that replicates the dynamics (loss of power/control/safety)
of the original trauma (Duckworth & Follette, 2012). Victims of sexual abuse may fear
retraumatization when undergoing a gynecological exam, thus decreasing the chances of seeking
cervical cancer preventive care.
According to the National Sexual Violence Resource Center (NSVRC), in the U.S., 1 in 5
women reported completed or attempted rape at some point in their lifetime. In other words, one
in three women experienced some form of contact of sexual violence in their lifetime (Morgan &
Kena, 2019). The percentage of persons who experienced rape or sexual assault, aggravated
assault, or simple assault increased from 2015 to 2018 and the rate of rape or sexual assault
increased from 1.4 victims per 1,000 persons aged 12 or older in 2017 to 2.7 per 1,000 in 2018. It
is estimated that 734,630 people have experienced either threatened, attempted, or completed rape
in the U.S. in 2018 (Pennsylvania Coalition Against Rape, 2021). Moreover, 81% of women who
were raped reported significant short- or long-term impacts, such as post-traumatic stress disorder
(Pennsylvania Coalition Against Rape, 2021) Most findings support the fact that sexual violence
traumatizes women so greatly that they no longer seek a standard routine cervical cancer screeninga procedure important for their reproductive health (Farid, 2019). Female rape victims face more
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complicated barriers than women who do not have past history with sexual violence to cervical
cancer screening (Pap test , HPV test) because not only are their bodies considered as a piece of
evidence of sexual assault, but they can also be retraumatized during gynecological exams such as
Pap and HPV testing, which requires the insertion of a foreign body into their private parts (Haskell
& Randall, 2019).
Previous studies assessing the different reasons that might affect a woman's decision to get
cervical screening (Pap and HPV) reveal that a woman’s comfort and confidence is crucial to
understanding their willingness to get cervical screenings (Fiebig, Haas, Hossain, Street, & Viney,
2009). Other studies have extensively used qualitative (interviews, focus groups), quantitative
(surveys) and randomized trials to assess willingness barriers, but there are limited studies on
sexual violence’s impact on female victims seeking routine gynecological care (Du Plessis, 2007).
Hence, this study will focus on female sexual violence victims and their participation in cervical
cancer screening.
Problem Statement
There is a public health concern of lower participation in cervical screening among sexual
assault victims, with fear of secondary trauma associated with rape, i.e., an experience in physical
assault, including vaginal/anal penetration cited as one of the reasons. HPV and Pap tests both
consist of inserting a speculum into the vagina and collecting cells from the cervix – the lower,
narrow end of the uterus that is at the top of your vagina (Office on Women's Health, 2021). The
fact that cervical screening consists of a foreign object's insertion into the vagina is considered a
triggering factor that can cause a rape victim to relive the past traumatic experience (Farid, 2019;
Chivers-Wilson, 2006). Therefore, a Pap and an HPV test can lead to fear of retraumatization and
prevent female victims from participating in cervical screening.
3

Since fear of retraumatization is associated with victims remembering trauma-related
experience to the unwanted and forced sexual activities (Watson, 2016), this dissertation focuses
on sexual violence acts that includes forced genital penetration. Forced genital penetration may
impact rape victims’ decisions to seek standard cervical screening, a method that some of them
may consider as an intrusive re-experience and can lead to avoidance of secondary trauma
(Gonzalez, Jetelina, Olague, & Wondrack, 2018). Survivors of sexual assault have higher rates of
anxiety compared to the general population (Chen, et al., 2010). Further, anxiety and powerlessness
have been cited as barriers when it comes to cervical screening Akinlotan et. al. (2017), found that
anxiety about the procedure was the third most commonly agreed-upon barrier to cervical cancer
screening. Cervical examinations that require inserting an instrument through the vagina and
reaching the cervix area—including Pap and HPV tests—can be retraumatization triggers for
sexual assault victims, reminding them about the previous sexual assault trauma (Farid, 2019). Due
to a victim’s fear of retraumatization, the current study aims to address a knowledge gap in the
current cervical screening literature and examine whether past rape trauma decreases a victim’s
participation in cervical cancer screening, (Pap and HPV tests). Through this study, an alternative
way of testing may be established to encourage higher participation from this vulnerable
population.
Purpose of Study
The purpose of this study is to examine whether sexual assault might impact a female
victim’s willingness to undergo cervical cancer preventive screening consisting of Pap and HPV
testing. This study investigates the association between history of sexual violence and the female
victim’s level of participation to routine cervical screenings.
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Research Questions and Hypotheses
Pap and HPV tests both require insertion of an instrument through the vagina and reaching
the cervix area, which may be a trigger for retraumatization in female sexual abuse victims who
have experienced sexual violence with vaginal or anal penetration. Thus, this study will address
the following research question: “Does female rape victims’ experience of sexual abuse impact
their decision-making process with regards to getting routine cervical cancer screening?”
Specifically, “Does a history of sexual violence predict participant willingness in routine cervical
cancer screening consisting of Pap and HPV testing?”
The central hypothesis of the current study is that a history of sexual violence for women
is associated with a decrease in getting Pap and HPV tests, as previous studies have indicated that
a woman’s comfort and confidence is a major factor in her decision to get a gynecological
examination.
Advancing Scientific Knowledge
Previous studies on sexual violence and its relation to the victim’s participation in cervical
cancer screening have involved either both men and women, have focused on multiple cancer
screening procedures (prostate, breast, and cervical), or have concentrated on one state using a
BRFSS survey (Alcalá, Keim-Malpass, & Mitchell, 2018). Another study assessed the relationship
between rape and cervical cancer screening participation using the 2014 Kansas BRFSS Survey;
however, the data they analyzed only included the Pap test (Bosch, 2017).
Therefore, in the current study, we seek to advance current scientific knowledge by
assessing the level of participation in Pap and HPV testing among women with a past experience
of sexual violence, considering that these tests may trigger retraumatization. Considering the
improvements made through health coverage and access to preventive care for these women, a
5

statistical analysis on datasets from BRFSS survey on two states was conducted. The hope is that
the results of this study will not only be able to examine the relationship history of sexual assault
and cervical cancer screening, but to also shed light to alternative testing methods that could be
given to help this vulnerable population have a more comfortable experience (and higher
participation) with these preventive screening procedures.
Significance of the Study
Cervical cancer was previously the leading cause of death for women in the U.S. Death
rates have decreased due to regular cervical screening. However, populations that are not
screening-such as victims of sexual violence-may have their health unknowingly deteriorating,
becoming a major public health concern. Moreover, not knowing the impacts sexual violence can
have on an adult’s participation in routinary cervical cancer preventive screening can slow down
the process of public health program participation and exclude the vulnerable population from fully
accessing to services that might save their lives. It is crucial and relevant to public health delivery
to provide recommendations that will increase rape victims’ willingness to get preventive
screenings for cervical cancer and give them confidence to undergo said examinations.
One of public health’s core values is to allocate tools and services that will help all
populations, especially the hard-to-reach populations, have access to health programs and services.
Some groups of people may have difficulties when trying to access healthcare services or may feel
unconfident about reaching out for healthcare services that they can benefit from and prevent them
from being at risk for certain diseases and conditions. This study provides further understanding
into cervical cancer prevention barriers of a specialized population, consisting of sexual assault
female victims, who have been impacted by their past experiences of abuse. This further
explanation highlights how adapting delivery of a service might bring positive change to seeking
6

behaviors among vulnerable populations and increase participation in preventive care campaigns,
such as cervical cancer screening.
Rationale for Methodology
For this study, we used an assessment-based approach to evaluate the relationship between
sexual violence and the female rape victims' participation in cervical cancer screening, more
specifically Pap and HPV tests. When looking at data that provided us with critical demographics
to study relationships that may exist between sexual violence and participation in cervical
screening, we wanted to get access to data that contains information on both sexual violence
victims and their participation in Pap/HPV testing. Knowing the status of the population of interest
and the judicial protection from which they benefit (116th Congress (2019-2020), 2019) it was
uncertain for us to have direct access to their information or their contribution. The other approach
was to look for secondary data that provide de-identified information accessible for studies and
cover a larger population. However, while searching the American data collection process, we
found out that among all the surveys conducted in the U.S., BRFSS, the Behavioral Risk Factor
Surveillance System, was the one at this point, to conduct a yearly nationwide survey and included
questionnaire on demographic, cancer screening and on sexual violence (BRFSS, Behavioral risk
factor surveillance system questionnaire, 2019). We used secondary data; therefore a statistical
analysis approach was best indicated to predict the female rape victim’s participation to the said
tests. Based on what has been done so far, we had estimated that getting results from the statistical
analysis provided information left unanswered by the extant literature and reduced the literature
gap.
Nature of the Research Design for the Study
To examine whether past sexual assault trauma decreases a victim’s participation in
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cervical screening, we worked with the BRFSS datasets to investigate the associations between
history of sexual violence and getting a Pap test and/or HPV test, while controlling for other
predictors. Searching for secondary data that included the variables of interest was arduous,
especially when looking for data that included information on sexual violence, the victims, and
cervical screenings. Searching for national surveys with relevant data and under several
recommendations led us to the BRFSS, the nation’s premier system of health-related telephone
surveys that collect state data about U.S. residents regarding their health-related risk behaviors,
chronic health conditions, and use of preventive services (BRFSS Questionnaire, 2009). This
national yearly survey consists of modules that not only assess demographics, but also allow each
state to add questions that they found critical to evaluate their population and other phenomena.
To help predict the level of participation in routine cervical screening, and after reviewing other
studies, a statistical analysis that not only predicts a relationship between variables but can also be
used for hypothesis construction and testing to validate assumptions is needed (see Figure 1).
To assess rape's impact on the female victim’s medical decision-making and how an
alternative screening approach to the standard cervical cancer screening can affect their decision
to get a pelvic exam, we used a quantitative research approach. Further, we conducted various
models of analyses to examine the "independent" influence of access to healthcare and healthcare
providers on the associations, corrected for age, educational attainment, income, sex, and
race/ethnicity.
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Figure 1: Conceptual Framework

Assumptions and Limitations
The assumptions of this study included that female rape victims face psychological barriers
that might prevent participation in cervical cancer screening. Examining the impact of a sexual
assault on a woman’s willingness to get a Pap or HPV test is essential for public health. With
limited studies on sexual violence and its impact on a female victim seeking routine screening, this
study aimed to shed light on barriers to participation in preventive cervical screenings from a group
of women suffering from a traumatic past experience (Cadman et al., 2012). Additionally,
exploring how an alternative method to delivering preventative cervical care might impact rape
victims’ participation to cervical cancer screening may be beneficial to further research with
actionable outcomes.
This study was limited to the use of secondary data from BRFSS. Since we had access to
only two states’ data out of the eleven that met the requirements of our quantitative study, our
statistical analysis was limited to the data from New Mexico and Connecticut. Furthermore, we
9

used the available modules and questionnaires that match our study population and outcome of
interest from the 2018 BRFSS data. However, with fewer previous studies that have looked at the
association between sexual violence and cervical cancer screening using BRFSS datasets, we
acknowledged that each of the previous BFRSS studies have each used different survey year
collections (Watson, 2016; Alcalá, Keim-Malpass, & Mitchell, 2018). Also, previous studies using
BRFSS have been conducted using data collected from different states or only one state. We noted
that cervical screening guidelines, health coverage and access to care are evolving and the
recommendations that were made in 2004 or 2012 were different than those made in 2018. We
then decided that this study would assess the association between rape and cervical screening using
relevant information that were available in 2018 and compared with the findings of previous
BFRSS studies.
Definition of Terms
Cervical Cancer Screening: The screening is looking for cancer before someone has the
symptoms and is usually part of a woman's health checkup. There are two types of tests: the Pap
test and the HPV test. For both, the doctor or nurse collects cells from the surface of the cervix.

HPV: HPV stands for human Papillomavirus and comprises a group of more than 200 related
viruses, some of which are spread through vaginal, anal, or oral sex. Sexually transmitted HPV
types fall into two groups, low risk and high risk. Low-risk HPVs mostly cause no disease.
However, a few low-risk HPV types can cause warts on or around the genitals, anus, mouth, or
throat. High-risk HPVs can cause several types of cancer. There are about 14 high-risk HPV types.
Two of these, HPV16 and HPV18, are responsible for most HPV-related cancers (Understanding
HPV and Pap Test Results).
10

HPV Test: Looks for cervical infection by high-risk types of HPV that are more likely to cause
pre-cancers and cancers of the cervix. The test can be done by itself or at the same time as the Pap
test (called a co-test) (with the same swab or a second swab), to determine your risk of developing
cervical cancer. The American Cancer Society recommends a primary HPV test as the preferred
way to screen for cervical cancers or pre-cancers in individuals 25 to 65 years with a cervix.

Papanicolaou test (Pap Test): The Pap test looks for cancers and precancers in the cervix. The
cervix is the lower part of the uterus (womb), which opens into the vagina. the lab checks the
sample for cancer cells or abnormal cells that could become cancer later (Dzuba, et al., 2002).

Rape: The U.S. Department of Justice defines rape as “the penetration, no matter how slight, of
the vagina or anus with any body part or object, or oral penetration by a sex organ of another
person, without the consent of the victim.” The federal government uses this legal definition to
collect information from local police about rape (An Updated Definition of Rape, 2017).

Retraumatization: Retraumatization is the exposure to multiple physically and/or psychologically
traumatizing events, such as multiple exposures to one type of traumatic event and/or multiple
exposures to many different types of traumatic events (Lawson, Skidmore, & Akay-Sullivan,
2020).

Sexual Assault: Sexual assault is any type of sexual activity or contact, including rape, that
happens without your consent. Sexual assault can include non-contact activities, such as someone
“flashing” you (exposing themselves to you) or forcing you to look at sexual images (Sexual
assault, 2019).
11

Trauma: Trauma is an emotional response that occurs as a result of violence, abuse, neglect, loss,
disaster, war and other emotionally harmful experiences. Longer term reactions include
unpredictable emotions, flashbacks, strained relationships and even physical symptoms like
headaches or nausea. Trauma is a widespread, harmful, and costly public health problem and has
no boundaries with regard to age, gender, socioeconomic status, race, ethnicity, geography or
sexual orientation (U.S. Department of Health and Human Services, 2014).
Chapter 1 Summary
This chapter established that the level of participation to cervical cancer preventive

screening, specifically PAP and HPV tests that requires the insertion of a foreign object to the
vagina, of female victims of sexual abuse may be affected by their past traumatic experience and
may trigger retraumatization. Examining the extent of this effect will shed light to possible
alternatives that can favorably impact their approach to these tests. This study proposes to examine
the association between a history of sexual assault and participation of the female victim to cervical
cancer screening, as well as provide recommendations to facilitate their increased participation.
The remaining four chapters will describe this study’s approach, go through an extensive
literature review, provide details on the methodology, and finally provide ample information from
the data collection, the data analysis to the data interpretation and recommendations. Chapter 2
consists of a thorough literature review of studies focusing on sexual violence victims and
participation in routine cervical cancer screening among other vulnerable populations facing
various barriers such as healthcare access, fear, and socio-economic status.

12

CHAPTER 2. LITERATURE REVIEW

Introduction
Cervical cancer is caused by the human Papillomavirus (HPV), the most common viral
infection of the reproductive tract. Although effective preventive measures are available (Pap and
HPV tests), some women face barriers that hinder their participation in his routine screening. (Defo
& Domgue, 2020). One such population is women victims of sexual violence—defined as victims
who have experienced sexual violence with or without vaginal or anal penetration. Many victims
face long-lasting emotional trauma, including a lack of confidence and a fear of secondary trauma
while attempting to participate cervical screening—an invasive procedure. However, there is little
research available to develop effective interventions. This study’s goal was to fill gaps by
investigating the impact of sexual violence on female victims’ participation in standard routine
cervical screening (Farid, 2019).
Several vulnerable populations have been identified as having barriers to cervical
screenings, including women from developing countries, women living in disadvantaged areas and
those belonging to minority communities (Defo & Domgue, 2020). Additionally, barriers to pelvic
examination have been observed among displaced or immigrant women and those among the
transmasculine community (Markova, Sandal, & Pallesen, 2020) (Reisner, et al., 2018).Some of
these women are dealing with factors that may limit them from seeking testing. Notable factors
include socioeconomic status, beliefs, cultural influences, fear, health illiteracy, limited school
attainment, and distrust in healthcare (Kobetz, et al., 2017; Shedlin, Decena, Mangadu, &
Martinez, 2011).
A less studied population that has significant barriers to cervical screening exists among
women who are victims of sexual violence. Although there is extensive research on multiple
13

vulnerable populations and the barriers, they might face regarding getting screened, there is a lack
of research examining those with a history of sexual violence, especially studies assessing what
might prevent victims from undergoing a Pap and HPV test. Some studies have investigated rape
victims' confidence and trust in healthcare regarding gynecological examination and routine
cervical screening (Farid, 2019). Other studies have examined rape victims' feelings and
perspectives towards cervical screening and have indicated that this population is amongst the most
vulnerable and are at higher risk of developing cervical cancer (Farid, 2019; Kappler, 2011; Jones,
2013). It is critical to investigate this topic in depth, in order to increase cervical cancer screening
among a population at high risk of cervical cancer yet afraid of retraumatization. Further,
investigating in depth would also provide more information and clarity to barriers and then
identifying and addressing those barriers would increase uptake on cervical cancer screening,
increase adherence to routine screening and overall reduce incidence of cervical cancer and early
death.
This study took an explorative approach to assess how a history of sexual violence may
impact a woman’s participation in cervical cancer screening.

Before we conducted the

multivariable logistic regression analyses, a literature review was thoroughly conducted to look at
previous studies conducted so far in our area of interest and look at similar phenomena and other
factors that contribute to creating barriers preventing vulnerable populations from seeking
preventive cervical screening.
Effect of Sexual Violence
Retraumatization is a conscious or unconscious reminder of past trauma that results in a reexperiencing of the initial traumatic event. It can be triggered by a situation, an attitude or
expression, or by certain environments that replicate the dynamics (loss of power/control/safety)
14

of the original trauma (Duckworth & Follette, 2012). According to the National Sexual Violence
Resource Center, NSVRC, in the U.S., 1 in 5 women and 1 in 10 men experienced completed,
attempted rape or sexual coercion at some point in their lifetime at some point in their lives
(National Sexual Violence Resource Center of America, 2011). Also, 1 in 3 women and 1 in 6
men in the U.S. experienced some form of contact sexual violence in their lifetime (National Sexual
Violence Resource Center of America, 2011). Moreover, 81% of women and 35% of men report
significant short- or long-term impacts such as Post-Traumatic Stress Disorder (PTSD) (Morgan
& Kena, 2019). Also, according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth
Edition (DSM-5), PTSD involves a set of symptoms that develop in the wake of exposure to
specific qualifying events, including sexual assault DSM diagnostic criteria for PTSD include four
“clusters” of symptoms experienced in reaction to traumatic events (Dworkin, et al., 2019).
Reexperiencing symptoms involve persistently reliving the sexual assault, including
nightmares, flashbacks, and intrusive memories. Avoidance symptoms include avoidance of
trauma-related stimuli, such as situations that remind the survivor of the sexual assault, and sexual
assault-related emotions, thoughts, and memories (Dworkin, et al., 2019). Anxiety has been cited
as one of the barriers when it comes to cervical screening and one study stated anxiety and fear
about the procedure was the third most commonly agreed-upon barrier (38.7%) (Akinlotan, et al.,
2017), but there is no specific indication stating that anxiety was related to trauma or sexual assault.
Although not every woman who has been sexually victimized develops PTSD, there are
certain psychosocial factors (e.g., abusive family members, abusive partners, child sexual abuse,
overall levels of stress in women’s environment) that make women particularly vulnerable to
developing PTSD and other forms of psychopathology (Chivers-Wilson, 2006). Furthermore, after
an assault, the victims experience the Rape Trauma Syndrome (RTS), which affects not only
victims of rape, but also victims of all types of sexual violence and would perhaps be better labelled
15

as Sexual Assault Trauma Syndrome (RAINN, 2008). In addition, some studies mention that from
the initial assault trauma onset, secondary trauma can occur when victims seek assistance from
medical or healthcare professionals. For individuals who are survivors of sexual assault, routine
doctor’s visits can bring with them added layers of stress, particularly cervix exams and Pap smears
(Farid, 2019). These can be especially uncomfortable for sexual assault survivors because they
require physicians to examine the sites where their sexual trauma occurred, which can be a
triggering experience. Healthcare providers can face many barriers to screening patients for sexual
trauma history, including lack of training, the frustration that they may not be able to help the
patient adequately, and difficulty discussing this sensitive topic (Watson, 2016). Due to the
negative perceptions of routine gynecological care amongst rape victims, those women are less
likely to receive routine Pap smears and, therefore, at higher risk of developing preventable
diseases, such as cervical cancer. The sensations associated with cervical exams are frequently
referred to as retraumatization triggers for victims and survivors of sexual assault, inducing
flashbacks, and other re-experiencing symptoms.
The research question for this study that seeks to find the association between a female’s
past sexual violence experience and their willingness to undergo Pap and HPV tests is since there
is a lesser participation to gynecological exams in the said vulnerable population, yet the
association to the fear of retraumatization has not been properly studied yet. We maintain that this
association may be significant, and that once properly understood, alternative testing methods may
be recommended to increase the female victim’s confidence and willingness to undergo cervical
cancer preventive screening.
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Review of the Literature
I. Overall Studies on Vulnerable Groups of Women in the U.S.
a.

Overview
While working on this dissertation, we started by reviewing the overall vulnerable women

groups that previous studies were interested in assessing their participation in standard cervical
screening, finding their barriers to screening, and improving their Pap and HPV testing experience
in the U.S. using a self-screening test.
b.

Minorities and Immigrants
i. Randomized Trials on Minorities and Immigrants Women in Florida
One study conducted a randomized controlled trial among 600 Haitian, Hispanic, and

African-American women from the South Florida communities of Little Haiti, Hialeah, and South
Dade amongst women aged 30–65 who had not completed a Pap smear screening in the past three
years (Kobetz, et al., 2017). The participants were randomized into two groups: 1) HPV selfsampling delivered in-person (IP) by a Community Health Worker (CHW; IP+SS) or 2) HPV selfsampling delivered via US mail (SS+Mail). The study’s approach was to examine the effectiveness
of HPV self-sampling delivered via in person versus by US mail for medically underserved
Hispanic, Haitian, and non-Hispanic Black women living in South Florida. Based on evidence that
HPV self-sampling has previously been shown to increase cervical cancer screening among ethnic
minority and immigrant women, the study’s aimed to identify potential barriers that might prevent
them from getting cervical screening. The study found that women faced barriers that include lack
of trust, lack of knowledge, lack of health insurance and access, and cultural beliefs regarding
disease prevention. It also found that mailed HPV self-sampling is an effective strategy to increase
cervical cancer screening among underserved immigrant and ethnic minority women (Kobetz, et
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al., 2017).
ii. Review of Medical Record Among Minorities Using Safety-Nets Care
A study found that women in safety-net institutions were less likely to seek available
cervical screening, and one of the studies has examined HPV testing among patients in a clinic in
Miami (Ilangovan, et al., 2016). The study consists of women who were offered HPV self-sampling
or traditional Pap smear screening. The acceptability of HPV self-sampling among patients and
clinic staff was assessed. If traditional screening was preferred the medical record was reviewed
and a total of 180 women were recruited (134 Latinas and 46 Haitian). The study’s objective was
to know if the study participants would prefer to participate in cervical screening by choosing either
the standard of care or using a self-test alternative-this is to evaluate whether an alternative would
increase women's participation in cervical screening and reduce their barriers. The author found
that for such populations, including immigrants and minorities, access to care, lack of insurance,
no usual source of care, and lack of financial resources are repeatedly identified as significant
barriers to routine Pap smear screening. From the study’s results, the authors observed that of the
180 participants who were offered HPV self-sampling, 121 accepted self-sampling method of
testing and all of them had it done (Ilangovan, et al., 2016). The study concluded that HPV selfsampling was feasible and had high acceptability among patients (Ilangovan, et al., 2016).
c. The Marginalized: Transmasculine Community
i. Self-Report Survey and Interview Study
One of the marginalized populations found across the literature reviewed included the
transmasculine (TM) community who consist of individuals assigned the feminine gender at birth
and have transitioned later in life. A study on TM people and self-sampling acceptability found
that neither the 2016 American Congress of Obstetricians and Gynecologists (ACOG) cervical
cancer screening recommendations nor the most recent 2012 U.S. Preventive Services Task Force
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recommendations for cervical cancer screening address screening among TM individuals
specifically (Reisner, et al., 2018). TM individuals are hard to reach and might often require a
more advanced screening adaptation. Among the barriers that TM individuals might face, pelvic
exams, including a speculum exam for collecting cervical screening specimens, can cause
discomfort and worsen feelings of gender dysphoria among transgender individuals (Reisner, et
al., 2018). However, in past research, TM individuals have expressed interest in alternative
cervical cancer screening methods that do not require a speculum exam.
The study’s method consists of 150 TM participants with a cervix (mean age = 27.5 years;
SD = 5.7) who completed a one-time study visit comprised of a self-report survey, self-collected
vaginal HPV DNA swab, clinician-administered cervical HPV swab, and brief interview on
acceptability of clinical procedures (Reisner, et al., 2017). Participants were randomized to
complete either self- or provider-collection first to minimize ordering effects. The study revealed
in the exit interviews that the self-collected vaginal HPV swab was highly acceptable to TM
participants, with over 90% endorsing a preference for a self- over-provider-collected swab
(Reisner et al., 2018b). The study results also indicated that many TM participants indicated the
importance of having alternative cervical cancer screening options and concluded that selfcollected vaginal swabs are highly acceptable to TM as a means to test for HPV.
The same author conducted another study on the TM population but had a different method
and purpose. The method of this study was a mixed-methods biobehavioral investigation enrolling
150 sexually active TM to (1) assess the clinical performance and acceptability of a vaginal selfswab for HPV DNA testing compared to provider cervical swab and cervical cytology, and (2)
gather acceptability data on self-collected specimens for other Sexually Transmitted Infections,
STIs (Reisner, et al., 2017). The study method consists of quantitative assessment, venipuncture
19

for syphilis testing and HIV testing, randomization, collection of biological specimens/biomarkers,
participant and provider satisfaction survey, and qualitative exit interview. The result of this study
has indicated that a less-invasive patient-centered strategy may also generalize to other at-risk TM
populations that face barriers to routine cervical cancer screening.
ii. Mixed-Methods Study Among Transmasculine Community in Boston
A mixed-methods study (in-depth interviews and survey) study was conducted at Fenway
Health, a Federally Qualiﬁed Health Center and research facility specializing in primary care for
sexual orientation and gender identity minority people in Boston. The TM population, who are
individuals who have a masculine spectrum gender identity, but were assigned female sex at birth,
face barriers that might prevent them from cervical screening. The study identified that standard
screening was a source of physical discomfort, was emotionally invasive, and provoked gender
discordance, compared to using an alternative approach that promotes a greater sense of agency
and control for the test takers (McDowell, et al., 2017).
iii. Discussion
Studies on TM individuals concluded that TM patients unwilling to undergo a standard
Pap/HPV exam found that health providers should be able to present an alternative to TM patients
that will make them more comfortable to participate in cervical cancer screening (McDowell, et
al., 2017; Reisner, et al., 2017; Reisner, et al., 2018).

II. Rape Victims Barriers & Participation in Cervical Cancer Screening in the U.S.
a. Overview
Some studies have been conducted to assess under-screened population barriers to cervical
cancer screening and self-sample acceptability, but limited studies are yet to be found on rape
victims' willingness to get HPV testing and their self-sample acceptability. Looking at significant
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databases, including PubMed, PsycINFO, Web of Science, and even searching through Google
Scholar, only a few studies have been found to assess rape victims and willingness to get screened.
However, the few studies that were retrieved provided information for this study's research
questions and study method development. We found five studies and articles that assess rape
victims' experience and its impact on their willingness to undergo cervical cancer screening.
Among the five findings, we can count two scientific articles on rape and access to gynecological
tests in the U.S. (Farid, 2019; Watson-Johnson, Townsend, Basile, & Richardson, 2012).
b. Barriers
i. Statistical Analysis Using Kansas 2014 BRFSS Survey
One of the studies conducted in the U.S. looked at the association between sexual assault
among men and women with cancer screening behaviors, including cervical cancer screening. The
study method consists of gathering data from the 2014 Kansas Behavioral Risk Factor Surveillance
System. This survey is conducted annually via telephone. Kansas, like other states, has optional
question modules that are administered as the state chooses to. A total of 13,356 respondents
participated in the survey and were 21 years or older (i.e., the age at which cancer screening is first
recommended). Of these, 11,207 had complete data for the sexual assault variables. The 2014
Kansas BRFSS included a sexual violence module that assessed the lifetime experience of sexual
assault. Logistic regressions were used to calculate odds of ever engaging in specific screening
behaviors (clinical breast exam [CBE], mammogram, Pap test, colonoscopy/sigmoidoscopy, fecal
occult blood test and prostate-specific antigen [PSA] test) and current compliance with cancer
screening recommendations (CBE, mammogram, Pap test, colorectal cancer screening, and PSA
test), with lifetime sexual assault as the independent variables. Data from the 2014 Kansas
Behavioral Risk Factor Surveillance System (BRFSS) survey and the data analysis consisted of
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multivariable analyses as potential confounders using STATA. The study also found that a history
of sexual assault was associated with lower odds of compliance with cancer screening procedure
with the exception of colorectal cancer screening. Sexual assault was associated with 51% lower
odds of PSA screening (AOR = 0.49, 95% CI = [0.25, 0.99]), 27% lower odds of CBE (AOR =
0.73, 95% CI = [0.58, 0.90]), 30% lower odds of completing mammograms (AOR = 0.70, 95% CI
= [0.56, 0.87]), and 31% lower odds of Pap testing (AOR = 0.69, 95% CI = [0.56, 0.84]). Results
from this study suggested that alternatives to currently recommended procedures, like selfcollection of HPV or modified screening procedures may be a promising route to increase current
compliance with cancer screening among a population that may avoid these procedures due to pain
or fear of retraumatization (Alcalá, Keim-Malpass, & Mitchell, 2018).
ii. Multivariate Logistic Regression on History of Sexual Violence and Cancer
Screening from 2006 BFRSS
Another study also used information from the 2006 BRFSS data collected from 11 states
and one U.S. territory to investigate the association between sexual violence victimization,
including completed unwanted sex and cancer screening behaviors (Watson-Johnson, Townsend,
Basile, & Richardson, 2012). The method used for the study analyzed data from the 2006
Behavioral Risk Factor Surveillance System Violence, SV, (BRFSS) from 11 states and 1 territory
(U.S. Virgin Islands) that administered the Sexual Violence module to describe demographic
characteristics, quality of life, health status, cancer screening behaviors, healthcare coverage, and
use of healthcare services for 58,665 women and men who reported SV victimization compared to
women and men who did not. Definition of having a history of SV for this study is adult
respondents who answered yes to any of the following questions: (1) unwanted touching of sexual
parts of the body within the past 12 months, (2) exposure to unwanted sexual situations that did
not involve physical touching within the past 12 months, (3) unwanted sex at any time in their
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lives, or (4) ever experiencing attempted unwanted sex. For this study, the statistical significance
was determined using chi-square tests and multivariate logistic regression. The results suggested
that sexual violence may have a negative association with general healthcare use, including breast
cancer screening for women, and recommend that healthcare providers should consider sexual
violence as a potential barrier for women who report not being up-to-date with mammography
screening. Even though the study assessed the association between sexual violence and breast
cancer screening, we found that it provides information on the effect that rape can have on victims’
participating to cancer screenings (Watson-Johnson, Townsend, Basile, & Richardson, 2012).
iii. Online Survey via the National Association for People Sexually Abused in
Childhood (NAPAC)
Moreover, the third study conducted in the U.S. consists of women visiting the National
Association for People Abused in Childhood (NAPAC) website, who had been sexually abused,
were invited to complete a survey on cervical screening. The questionnaire included closed
questions on demographic characteristics and cervical screening attendance, open questions on
barriers to screening, and the opportunity to submit suggestions to improve this experience for
women who have been sexually abused. Content analysis was used to code responses to the open
questions. This study suggested that intimate gynecological examinations can be incredibly
stressful for women who have been abused because of the parallel situation such as perceived loss
of control, the power disparity, and the physical sensation of the examination that can be triggering
factors for retraumatization. Furthermore, the study identifies barriers to cervical screening
attendance that can face rape victims, and some of them include (Cadman, Waller, Ashdown-Barr,
& Szarewski, 2012):
● Self-worth: Women who have been abused reported to have feelings of “not physically
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normal”, had “signs of abuse or trauma” , feelings of “shame” and “guilt” and there was
even the idea that an abused woman's “sense of entitlement to good treatment has been
taken away”.
● Power disparity: Abused women reported feeling vulnerable, like someone having
control over them being “similar to the control that is suffered during abuse and feeling
“like someone who have little choice over the test” and “it is not what I chose to do myself
but what someone else is telling me I need to do”.
● Trust and safety: Some of the abused women reported problems disclosing that they had
been abused and also how this might impact on disclosure: “too difficult to tell ... feel like
nobody would understand safe”.
● Sexual victimization: Study participants compared their previous experiences with
cervical screening being “exactly like it used to happen when I was abused” and one of
them describe it as “legalized rape”. Abused women commented on the intrusive and
invasive nature of the test and how they did not like to be “lying down exposed … having
somebody touch me in that area”.
● Sharing control: Some women wanted to be in control of their body and the procedure
and requested to be able to say “stop” and walk away without feeling that they are being
judged. Also, some wanted to be more involved in the procedure either by inserting the
speculum themselves or doing their own smear with supervision and others requested a
self-test that they might do in the privacy of their own home.
● Mechanism of the examination: The position of being laid back during the cervical
screening reminded some of the abuse situation: “I hate being on my back while things are
done to me” and noted difficulties with penetration “part of the abuse was to force things
inside me, and this seems to be the same kind of thing”.
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iv. Articles on Sexual Violence and Medical Visit Anxiety
One of the articles that addressed the association between rape victims and their
participation in cervical screening also indicated that women who have experienced sexual
violence or trauma are more likely to have anxiety about medical visits, particularly seeing a
gynecologist and receiving a pelvic exam. The article also mentioned that some rape victims might
be affected by post-traumatic stress disorder (PTSD), making them feel as though they are being
re-traumatized by a pelvic exam, and a gynecologic visit or pelvic exam may feel insurmountable
to them (Farid, 2019). A report on a general literature review from Australia stated that due to the
absence of any direct evidence from the systematic review, a general review of the literature was
performed to ascertain the effectiveness of cervical screening in women who had been sexually
abused as children, 16 studies were identified.
v. Discussion
Across the literature review on studies conducted to assess women victim of rape willing
to participate in cervical cancer screening, similar outcomes were found to address rape impact on
the victims and improve their screening participation and experience. Results suggest that
alternatives to the standard recommended procedures may be a promising approach to increase
participation and adherence to cancer screening among populations that may avoid gynecological
examination due to fear of retraumatization (Alcalá, Keim-Malpass, & Mitchell, 2018). Also, we
found suggestions to improve the experience for sexually abused women; the screening procedure
should focus on sharing control, meaning to let victims regain control over their bodies (Cadman,
Waller, Ashdown-Barr, & Szarewski, 2012).
Learning how rape can affect women and influence their cancer screening attendance is
crucial to increase their access to gynecological care and improve their experience during a cervical
examination. Previous studies on the topic help this study design development and provide
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direction on the approaches that might yield future studies information.

III. Sexual Violence Trauma and Participating in Cervical Screening
a. Overview
This section is about Papers on sexual violence trauma and its impact to the victims
accessing cervical cancer screening, and their fear of retraumatization searched through various
databases such as PubMed, WebofScience, PsycInfo, Google Scholar, without a year limitation. A
total of relevant articles and dissertations that meet the searching criteria, including rape victims,
retraumatization/secondary traumatization, and cervical or cancer screening, yielded three
significant readings.
b. Sexual Violence and Trauma
i. Re-Traumatization of Sexual Trauma in Women's Reproductive Health Care
Watson (2016) assessed fear of the rape victims' reproductive preventive care and how
health care providers can trigger retraumatization of previous sexual abuse through common
women's healthcare practices such as pelvic examinations that resemble a patient's previous
traumatic experience. The research Paper use database searches were conducted on PubMed,
PsycINFO, ERIC, CINAHL Complete, and Cochrane Library using the following keywords: posttraumatic stress, sexual trauma, and childbirth, prenatal care, or pelvic exam. The author then
selected relevant qualitative, quantitative, and review studies based on thematic material
addressing presentation of posttraumatic stress symptoms in one or more of the four designated
categories of female reproductive health care: gynecological care, prenatal care, labor and delivery,
and postpartum care and the publication dates reflected in the literature chosen for this review
ranged from 1992 to 2015. The dissertation compared how war veterans might experience a
flashback to a conflict after hearing a car backfire; a similar situation might happen with rape
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victims who can relive their trauma due to a trigger that mirrors their abuse, and such triggering
factors can include lying supine. The study mentioned that PTSD symptoms that can be present in
a woman who has been retraumatized were grouped into three categories: intrusion or intrusiveexperiencing, avoidance, and arousal. The study also suggests that rape victims can suffer from
sequelae, most severe in women who experienced completed, penetrative rape, longer duration of
abuse, and childhood sexual abuse.
The study is a meta-analysis that looks at studies with interest in female reproductive care,
rape victim and concludes that not only sexually traumatized women experienced gynecological
care differently than non-traumatized women, but also that one of the most physical triggers
encounters by sexual assault victims is the pelvic exams. It states that avoidance of gynecological
care due to sexual assault victims’ negative perceptions could lead to a lifetime of preventative
care avoidance, and also that insertion of the vaginal speculum and/or fingers during vaginal
examinations is often cited as a physical trigger that reminded women of their trauma.
ii. Fear of Secondary Trauma
Another scientific article: “The 'My Body Back' Clinic: a specialist cervical screening and
sexually transmitted infection testing clinic for women who have been sexually abused” about
sexual violence indicated that 1 in 5 women do not attend the cervical screening; among these are
those who have experienced sexual violence (Zelin, Cadman, Amara, Marnoch, & Vosper, 2017).
The article consists of women completing questionnaires before and after their appointment and
prior to the appointment, they ascertain the women's expectations from the clinic visit, their anxiety
levels and confidence in their ability to undergo a smear test. The study shows evidence that
suggests sexually abused women may be at increased risk of cervical cancer and avoid healthcare,
including cervical screening (Zelin, Cadman, Amara, Marnoch, & Vosper, 2017). Further, from
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the study, a freelance journalist interviewed women who had experienced sexual violence, and a
research nurse separately carried out a study in this group of women, researching access and uptake
of cervical screening. After listening to rape victims and their fear of participating in cervical
cancer screening, a clinic was launched to respond to victims' needs and demands (Zelin, Cadman,
Amara, Marnoch, & Vosper, 2017). From the article, it was found that sexual assault victims
wanted:
1. Disclosure of sexual violence
2. Safety
3. Trust, respect, and shared control
4. Communication-related to sensitivity
5. Understanding of common factors which potentially trigger adverse reactions including the
procedure, and the clinic environment, which commonly parallel the situation during the
sexual violence or subsequent medical examinations and time and space.
The article indicates that the clinic aims to meet the women's demands by ensuring a
collaborative experience rather than one where the cervical screening examination has control
over the victims.
iii. History of Sexual Violence and Cervical Cancer Screening
The study on history of trauma associated with a reduced likelihood of cervical cancer
screening leaded by Farley tested the hypothesis that a history of sexual trauma was associated
with a reduced likelihood of having had medically appropriate cervical cancer screening (Farley,
Golding, & Minkoff, 2002). The study consists of a case-control study using mailed self-report
questionnaires. The questionnaires were completed by an age-stratified random sample of adult
women members of a large health maintenance organization. The sample included 364 women
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who had received medically appropriate cervical cancer screening and 372 who had not. The result
indicates that women who had been sexually abused in childhood were less likely to have had a
Pap smear within the past two years. It also states that childhood sexual abuse remained associated
with reduced odds of Pap screening in logistic regression analyses that controlled for clinic
location, demographics, attitudes about Pap screening, and posttraumatic stress disorder
symptoms. It was determined that the interpersonal climate between a clinician and the patient
affects health outcomes. Therefore, it is a critical factor to improve women's comfort with
screening and that it is crucial to develop an intervention that will increase the participation of
women who have experienced sexual assault.
v. Discussion
These studies on rape victims, fear of retraumatization, and access to preventive women
care to inform how rape victims feel and perceive a routine cervical screening to prevent chronic
disease. Due to a past dolorous experience, rape victims might fear to come close to triggering
factors that might make them react and re-experience their abuse and learning what contributes to
the triggering effects can provide tools on how to address their condition and provide an alternative
procedure to pelvic exam that will feel less invasive to their body.
c. Rape Victims and Qualitative Study Approach
i. Interviews for Studies on Rape Victims
One of the studies relevant to this study’s target population used a qualitative approach on
rape survivor and interviewing practices. It stated that face-to-face interviewing is a common data
collection technique in violence against women research (Campbell, Adams, Wasco, Ahrens, &
Sefl, 2009).
Campbell’s study explains that before interviewing rape victims, the interviewer had to
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follow two crucial steps: First, interviewers must learn about violence against women itself, and
second, involves teaching how to administer the interview protocol itself. The study method
consists of structured interviews with primarily open-ended questions of 102 racially diverse rape
victims’ sample, plus using tape-recording (Campbell, Adams, Wasco, Ahrens, & Sefl, 2009).
During the interviews, the interviewers were requested to guide on how to interact with the
survivors throughout the interview using emphasized feminist interviewing principles. They
outlined six of the essential principles of feminist expectations, which are (Campbell, Adams,
Wasco, Ahrens, & Sefl, 2009):
1. The emotional well-being of the survivors was always their paramount concern.
2. Women needed to be given time to tell their stories in their own words.
3. The interviewer needed to show patience and respect while the women's stories unfolded.
4. Interviewers needed to encourage the participants to ask questions, be prepared to answer
their questions and engage in dialogue.
5. Interviewers needed to provide information to women that might have helped them
understand or normalize their experiences.
6. The emotional tenor of the interview needed to reflect warmth, compassion, and
understanding.
The results show that interviewers need to know about rape and its impact on victims. The study
participants raised four factors that they wanted the interviewer to know while preparing an
interview with a rape victim:
1. They wanted interviewers to know that rape happens to all kinds of women and that
survivors show their emotions in different ways,
2. Rape has a devastating impact on multiple facets of women's lives, so interviewers need to
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understand that recovery is a long journey, and they will be talking with women at very
different stages of that process,
3. Interviewers need to be respectful of the differences between personal knowledge and
learned knowledge, but both can help researchers appreciate survivors'' lived experiences
and,
4. Survivors wanted interviewers to use all this knowledge to help women feel comfortable
in the interview.
This literature contributes to public health by showing that sexual violence victims' fear of
secondary trauma may impact their cervical screening participation among studies conducted
worldwide. From this literature review, we can see that a wide range of methods were used to not
only assess the acceptability of an alternative procedure to the standard cervical screening, but also
to assess if vulnerable populations, including sexual assault victims and their willingness to get a
cervical screening using the standard physician assisted method or using a self-collection tool.
Two of the studies reviewed here indicated that their methods included rape victims, both men and
women. The first one used the Statistical Analysis Using Kansas 2014 BRFSS Survey in a study
on women and men with a history of sexual violence and their participation to various cancer
screenings (Alcalá, Keim-Malpass, & Mitchell, 2018). This study was able to explore sexual
assault impact on decision to get a standard cancer routine and therefore contributed to the
literature on assessing access to preventive care among sexual victims. The second study that
focused on sexual victims and used data from the 2006 Behavioral Risk Factor Surveillance
System Violence, SV, (BRFSS) (Watson-Johnson, Townsend, Basile, & Richardson, 2012). The
study mentioned that except for mammography screening, there were no associations found among
the other screening tests such as cervical screening and SV victimization in the multivariate models
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(Watson-Johnson, Townsend, Basile, & Richardson, 2012). Watson also added that it is possible
that some of the variables included in the multivariate model may have mediated the relationship
between SV victimization and adherence to cancer screening, which would explain why their
presence in the multivariate model rendered SV victimization insignificant (Watson-Johnson,
Townsend, Basile, & Richardson, 2012). More research is needed to explore this hypothesis and
understand the potential mediating relationships of the control variables and Sexual Violence
victimization in understanding cancer screening behaviors.
This review also indicates a niche for research on the association between sexual violence
and the level of participation in cervical screening. Through this literature, we found that some of
them yield recommendations that can be considered to prevent a rape victim’s fear of
retraumatization, therefore giving a way for future studies in improving their access to preventive
cervical cancer screenings.
Chapter 2 Summary
Previous studies on sexual violence and participation in cervical cancer have involved

either both men and women, have either focus on multiple cancer screening procedures (prostate,
breast, and cervical), or have concentrated on one state using a BRFSS survey (Alcalá, KeimMalpass, & Mitchell, 2018). Other studies focused on childhood sexual violence trauma or
conducted interviews approached a missing part that will focus on adult women with past sexual
violence and their participation in exclusively cervical screening. Also, the two studies that closely
match this study’s aim, which is to assess the relationship between rape and cervical screening,
are lacking some of the key components that will be included to this study methods and analysis.
The first one is based on the Statistical Analysis Using Kansas 2014 BRFSS Survey study
that mentioned that in 2014 only the question about having Pap was included in the question about
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having a cervical screening, and that the question about getting screened for HPV was added later
in the most recent BRFSS survey (Alcalá, Keim-Malpass, & Mitchell, 2018). This study will use
the cervical screening module questions which included both questions on having been tested for
Pap and having been tested for HPV. Using both Pap and HPV test for dependent variable will
allow our study to cover not only women who think they have received a Pap test, but also those
who believe that they instead received a HPV test following 2018 cervical screening guidelines
(since both Connecticut and New Mexico BRFSS surveys have been conducted in 2018), that
USPSTF has recommended co-testing (Pap testing plus HPV testing) for women aged 25 to 65
years since 2020 (US Preventive Services Task Force, 2018). Second, based on the study that used
Multivariate Logistic Regression on History of Sexual Violence and cancer Screening from 2006
BRFSS, as a recommendation and based on their results, they acknowledge that having control
variables might mediate getting cervical screening by sexual assault victims (Watson-Johnson,
Townsend, Basile, & Richardson, 2012). Therefore, it is recommended that more research is
needed to explore this hypothesis and this study will look at control variables such as having a
personal doctor and health coverage potential mediating relationships of sexual assault victims and
cervical cancer screening behaviors.
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CHAPTER 3. METHODOLOGY

Introduction
Rape victims—a population identified as vulnerable due to their past experiences with
abuse—not only frequently have post-traumatic stress disorder (PTSD) related to the rape trauma,
but also the fear of being retraumatized when they have to partake in activities that might remind
them of their abuse (Watson, 2016). A gynecological exam, including cervical cancer screening,
may be one of these activities. This study explored the impact that rape has on victims when it
comes to get screened for cervical cancer using data from BRFSS to later provide
recommendations to understand rape victims’ willingness to get screened for cervical cancer.
Statement of the Problem
There is a public health concern of lower participation in cervical screening among sexual
assault victims, with fear of secondary trauma associated with rape, i.e. an experience in physical
assault, including vaginal/anal penetration being cited as one of the reasons (Chivers-Wilson, 2006;
Carbon, 2012). HPV and Pap tests both consist of inserting a speculum into the vagina and
collecting cells from the cervix – the lower, narrow end of the uterus that is at the top of your
vagina. The fact that cervical screening consists of a foreign object's insertion into the vagina is
considered a triggering factor that can cause to relive a traumatic past experience for rape victims
(Farid, 2019). Therefore, a Pap and an HPV test can lead to fear of retraumatization and prevent
female victims from participating in cervical screening.
Due to a victim’s fear of retraumatization, the current study wanted to examine whether
past rape trauma would impact a female victim’s willingness to undergo cervical cancer cervical
screening, i.e., Pap test or HPV test. Furthermore, this study we also explorer the association
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between history of sexual violence and the female victim’s level of participation in routine cervical
screenings. Through this study, unanswered questions from previous studies were at some point
addressed and clarity on future recommendations based on previous findings were established.
Research Question and Hypothesis
To examine whether past onset sexual violence might affect a victim’s participation in
cervical screening, Pap or HPV test, the current study used secondary data from BRFSS, the
nation’s premier system of health-related telephone surveys that collect state data about U.S.
residents regarding their health-related risk behaviors, chronic health conditions, and use of
preventive services. The associations between history of sexual violence and the female victim’s
medical decision-making of getting a Pap/HPV test was investigated while controlling for other
major and other predictors: age, educational attainment, income, sex, and race/ethnicity. Therefore,
the specific research’s question this study addressed was: “Does a history of sexual violence
predict participation in routine cervical cancer screening consisting of Pap and HPV testing?”
To find out and understand if there is relationship between the predictor and the outcome,
we came up with the following null hypotheses (Alexopoulos, 2010):
1.

There is no statistically significant relationship between sexual violence and

likelihood of getting routine cervical screening (Pap and/or HPV).
2.

There is no statistically significant relationship between last 12-month sexual

violence and likelihood of getting routine cervical screening (Pap and/or HPV).
Alternative hypotheses:
1.

There is a statistically significant relationship between sexual violence and

likelihood of getting routine cervical screening (Pap and/or HPV.
2.

There is a statistically significant relationship between sexual violence and
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likelihood of getting routine cervical screening (Pap and/or HPV).
Research Design
The literature review indicated that previous studies on rape victims and retraumatization
did not directly investigate how sexual violence impacts participation in HPV tests. Multivariable
logistic regression analysis for this study allowed us to assess the impact of sexual violence and
explore how abuse can affect the victims in partaking in a clinician-assisted pelvic exam,
specifically a Pap test and/or an HPV test.
A multivariable logistic regression analysis in this study involved multiple variables
resulting in two outcomes (HPV test and Pap test), used widely in many industries, such as the
public sector and healthcare. Some of the advantages of using logistic analysis include that it
considers more than one factor of independent variables that influence the variability of dependent
variables, and the conclusion drawn can be more accurate. The multivariable logistic regression
for this study was to:
1. Predict associations between variables: must be determined for the purpose of predicting
the values of one or more variables based on observations made on the other variables.
2. Construct and test hypotheses: Specific statistical hypotheses, formulated in terms of the
parameters of multivariate populations, are tested. This is to be done to validate
assumptions and to reinforce prior convictions and,
3. Investigate dependence among variables: The nature of the relationships among variables
is of interest to know if all the variables are mutually independent or are one or more
variables dependent on the others.
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Population and Sample Selection
This study focused on US female sexual violence victims and their participation in cervical
cancer screening, specifically those from the states of New Mexico and Connecticut. Data from
the BRFSS surveys from these states were merged to obtain adequate sample size for statistical
analysis.
Instrumentation and Sources of Data
Using secondary data allowed us to get information that can later be used by researchers
interested in learning about rape victims' experience and their perception of pelvic exams (HPV
and PAP test). The BRFSS dataset will be used to conduct a regression analysis to determine if
there is an association between a history of sexual violence and getting cervical cancer screening,
specifically a PAP and HPV test.
The BRFSS survey consists of a core questionnaire with predefined modules that each state
must use each year to administer the survey to their population. Additionally, this survey allows
each state to add Centers for Disease Control and Prevention, CDC, optional modules that do not
appear to finalize annual national survey statistics, and individual states have the option to add
questions to their BRFSS questionnaires that are not currently part of the CDC core questionnaire
or optional modules (BRFSS Questionnaire, 2009).
The current study used the CDC optional module "Cervical Cancer Screening" and the
state-added "Sexual Violence" module. It is crucial to mention that concerning the stated-added
sexual violence module, each state has the opportunity to either use the old official CDC Module
17 on sexual violence or adopt a version adapted from the old version. Both types of modules
consist of questions that ask about participation in cervical cancer screening tests (HPV and PAP)
and questions on sexual violence. The following were the specific questions asked:
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Cervical Cancer Screening Module Questions
1. An HPV test is sometimes given with the Pap test for cervical cancer screening. Have you
ever had an HPV test? (HUMAN PAPILLOMAVIRUS)
2. How long has it been since you had your last HPV test?
3. Have you ever had a Pap test?
4. How long has it been since you had your last Pap test?
Sexual Violence Module Questions
1. Has anyone, not just an intimate partner, EVER forced you into unwanted sexual activity
after you said or showed that you did not want them to without your consent? (This includes
any type of unwanted sexual activity, not just penetration).
2. In the past 12 months, has anyone HAD SEX with you after you said or showed that you
did not want to or without your consent?
To get the datasets with the relevant modules for this study, a thorough search on the CDC websites
and each state’s public health department indicated that in the last five years, 11 states had
integrated both cervical cancer and sexual violence modules during an indicated year. The different
states that have used both modules included the following:
1. Arkansas, 2018
2. Maine, 2016
3. California, 2018
4. North Carolina, 2018
5. Oklahoma, 2019
6. New Jersey, 2017
7. New Mexico, 2018
8. Utah, 2018
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9. Connecticut, 2018
10. Massachusetts, 2016
11. Montana, 2016
To gain authorization to obtain and use BRFSS states data, emails and phone calls were
made to each of the 11 states to request access to the documents (codebook, dataset, and overview)
that will be used to perform statistical analysis. Two states agreed to send datasets. After data
request applications were filed, the two BRFSS datasets, both for the year 2018, were successfully
received. The current study used the Connecticut BRFSS dataset 2018 (BRFSS Questionnaire,
2009) and the New Mexico dataset 2018 (Union, Socorro, Ana, Miguel, & Baca).
The National Statistics on Domestic Violence shows that rates of reported rape, physical
violence, and/or stalking in their lifetime by sexual orientation found that 43.8% of lesbian women
/26% of gay men, 61.1% of bisexual women / 37.3% of bisexual men, and 35% of heterosexual
women / 29% of heterosexual men (National Sexual Violence Resource Center of America, 2011).
It also states that the rates of reported sexual violence, physical violence, and/or stalking in their
lifetime by race/ethnicity includes 45.1% of non-Hispanic Black women / 40.1% of non-Hispanic
Black men, 37.3% of non-Hispanic White women / 30.3% of non-Hispanic White men, 34.4% of
Hispanic women / 30% of Hispanic men, and 18.3% of Asian or Pacific Islander women / 13.7%
of Asian or Pacific Islander men.
In the New Mexico 20th edition of the statewide sexual assault and domestic violence
report, there were 1,524 criminal sexual penetration (rape) victims identified from the 1,443-law
enforcement sexual assault reports in 2019 and of these, 1,158 (88%) were female victims
(Caponera, 2010). Of the 1,303 reports of criminal sexual penetration that identified victim age,
the greatest proportion of all victims was in the age group 13‐18 (26%), followed by victims ages
19‐25 (17%), 26‐35 (16%), 7‐12(12%), and 36‐45(11%). From 2015‐ 2019, the age group with
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the highest average proportion of rape victims were adults 18 and older (48%) followed by
adolescents ages 13‐17 (26%) and children under 13 years old (26%). Also, most rape victims
identified by law enforcement are Hispanic, an average of 43% each year from 2015‐2019,
followed by Whites (non‐Hispanics) (40%), Native Americans (12%), Blacks (4%) and other races
(1%). In Connecticut, the sex crime statistics conviction from 2015-2019 indicates that sex
offender convictions have averaged approximately 530 a year for the last five years, but in 2019,
it increased to 523, closer to the average for the five-year period. There was a total of 2,651 sex
crime convictions in Connecticut from 2015 through 2019 (Kirby, 2020).
The New Mexico BRFSS survey collected sexual violence data on the entire study
population (N=6,713) and the Connecticut dataset collected data on half of the study population
(N= 4,705). Both datasets also include demographic data, which are part of the core questions and
include variables such as sex, age, race/ethnicity, income, and education attainment. Further, both
datasets included an optional module on health care access and include the questions on health
care coverage and access to a regular health care provider, therefore making the data accessible to
conduct our statistical analysis.
While choosing the BRFSS survey and year of interest, this study's essential aspect was to
analyze a survey that includes both modules, conducted the same year, and using the same
questionnaire for the sexual violence module. After conducting a quick frequency analysis, the
Connecticut survey yielded a sample of 351 over 2658 (13.2%) female adults (≥18 y) (Split 2),
and the New Mexico sample yielded 444 over 3617 (12.3%) female adults who answered ‘yes' to
the sexual violence question. Connecticut BRFSS respondents were asked whether anyone, not
just an intimate partner since they were 18 years old, ever forced them into unwanted sexual
activity after they said or showed that they did not want to or without their consent, for example,
they were drunk or asleep, or they thought they would be hurt or punished if they refused (BRFSS
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Questionnaire, 2009). The New Mexico sexual violence questions were slightly different and
asked respondents if anyone ever had sex with them after they said or showed that they did not
want them to or without their consent.
Predictors were chosen according to Andersen's model of health service utilization
(Andersen & Newman, 1973). We focused on the Individual Determinants of Health Service
Utilization; it is an underlying model that assumes that a sequence of conditions contributes to the
type of volume of health service a person uses is dependent on the predisposition of the individual
to use services; the ability to secure services; and the illness level:
● Predisposing Component: The propensity toward use can be predicted by individual
characteristics that exist before the onset of specific episodes of illness, but in this study,
instead of an illness, we will consider an experience of rape.
● Enabling Component: A condition that permits a family to act on a value or satisfy a need
regarding health service use is defined as enabling conditions that make health service
resources available to the individual.
● Illness Level: represents the most immediate cause of health service use.
For this study, the predispositions variables were age, sex, race/ethnicity (non-Hispanic
white, non-Hispanic black, and other (data on Hispanic respondents and other racial groups is
combined because of small sample sizes). Enabling factors were educational attainment, health
insurance coverage, and regular health care providers. Since this study was based on an experience,
we did not consider the illness level.
Data Collection and Management
To obtain the dataset for this study, the data providers requested to sign for a data request,
and each state provided us the right to use the data for this study’s purpose only. We were also
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required to use appropriate safeguards to prevent or disclose confidential information other than
as provided by agreement. For each state, acquired data were used following the confidentiality
and privacy agreements.
Data Analysis Overview
We conducted the logistic regression using SAS software to perform this study analysis.
Given the dependent variable is any of the standard cervical screening (Pap and HPV), we wanted
to make the dependent variable binary thus we had to eliminate all category 7 (Don’t know/Not
Sure) and 9 (Refused). After controlling for race, age, health care access, personal doctor, and
education, we probably lost some observations, but still had enough for statistical analysis. We
also had to transform age, race, education, and health care access to categorical variables. Also,
for demographic characteristics, the 2018 survey weights variables were provided by the CDC.
Since the sampling weight varies per dataset, we had the Connecticut datasets that used version 2
with the variable named _LCPWTV2 which was collecting multiple version questionnaires (split
2) and the New Mexico Dataset named _LLCPWT, which used the same questionnaire version
food all the survey participants (BRFSS Questionnaire, 2009).
The purpose of this research was to assess the likelihood of a sexual violence to participate
in cervical screening. We wanted to know if rape victims who suffer from trauma due to history
of forced penetration, might impact their decision to get tested for HPV and Pap. The research
methodology consisted of conducting a logistic regression analysis, while using the BRFSS survey
data that we received from two states, Connecticut, and New Mexico, which both had participated
in the 2018 National Survey. Both datasets have included the optional module on sexual violence
which asked questions on history of rape that included act of forced penetration that has occurred
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without consent. The research question was to know whether rape victims’ experience of abuse
impacts their decision-making process regarding getting routine cervical cancer screening.
Our null hypotheses were as follows:
1.

There is no statistically significant relationship between sexual violence and
likelihood of getting routine cervical screening (Pap and/or HPV).

2.

There is no statistically significant relationship between last 12-month sexual
violence and likelihood of getting routine cervical screening (Pap and/or HPV).

Alternative Hypotheses:
1.

There is a statistically significant relationship between sexual violence and
likelihood of getting routine cervical screening (Pap and/or HPV).

2.

There is a statistically significant relationship between sexual violence and
likelihood of getting routine cervical screening (Pap and/or HPV).

This chapter provided a narrative of the sample characteristics and demographics of the
participants in the study. We also provided validity and reliability of the data in statistical terms
for the statistical analysis and discuss the limitations we found while conducting the data analysis
and justified how the analysis aligned with the research question and hypotheses and was
appropriate for the research design.
Data Analysis Procedures
The analysis first started by combining the datasets. New dichotomized variables with
responses of 1 for Yes and 0 for No were to indicate participant’s getting each or both Pap and
HPV tests were created based on participant’s responses to questions for each cervical screening
test.
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Second, some continuous variables were categorized in the analysis. Age was transformed
into four groups based on the National Cancer Institute’s, NCI, recommendation for HPV and Pap
tests. In the most recent cervical screening guidelines, the NCI indicated that the recommended
range for cervical screening is now recommended from 25 to 65 years of age, and states that there
is more interest now in looking at people who had an abnormal screening test result at an older age
to see if they require more years of screening or more frequent screening (NCI Staff, 2021). Since
2020, women aged under 21 years old are not recommended anymore to get cervical screening
(NCI Staff, 2021). The 2018 guidelines indicated that preferred testing was: between 21 to 24 Pap
test every 3 years, between 25 to 29 Pap test every 3 years, between 30 to 65 Pap test every 3
years, HPV test every 5 years, or HPV/Pap cotest every 5 years, and for those aged 65 and above
No screening if a series of prior tests were normal (NCI Staff, 2021). Therefore, we recoded age
to:

Age Recorded
1-18 to 24
2-25 to 29
3- 30 to 65
4- 66 and up

The rest of recoded variables were changed to the following with ‘REFUSE TO ANSWER’ and
‘DO NOT KNOW’ to missing values and as follow:
HLTHPLN1REVISED (Health plan)
1-YES
0-NO
PERSDOC2RECODED (Personal doctor)
1-YES
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0-NO
RACEREVISED
1- White
0- Non-White
EDUCAREVISED (Education attainment)
1-No college
2- College
INCOME2REVISED (Income level)
1-Less than $75,000
2- $75,000 or more
HADPAP2REVISED (Ever had a Pap test)
1-YES
0-NO
HPVTESTREVISED (Ever Had a HPV test)
1-YES
0-NO
SEXWCREVISED (ever had forced sex)
1-YES
0-NO
WHSEXWCREVISED (had forced sex the last 12 months)
1-YES
0-NO
Pap_HPV_Test (had PAP/HPV test)
1-YES
0-NO
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Furthermore, to combine both HADPAP2REVISED and HPVTESTREVISED, we used
the concatenate method to merge both variables and achieve only the single cervical screening
variable that recognize if a survey participant had at least got one test, either Pap or HPV test, and
we named the variable Pap_HPV_Test. To obtain the Pap_HPV_Test variable, which can be
done by using the multiple if/then statement to recode the variables, we instead used the arithmetic
function Absolute Right (Abs) formula as follows: 0.5* (PAPTESTREVISED +
HPVTESTREVISED - Abs (PAPTESTREVISED - HPVTESTREVISED). The new variable
Pap/HPV resulted in having code where a YES and a NO answer becomes a YES, NO and NO
becomes NO, SYSTEM MISSING and YES becomes YES and finally, SYSTEM MISSING
and NO becomes NO.
Third, we conducted logistic regressions to test the null and the alternative hypothesis,
applying the sampling weight and the stratification variables. During the analysis, we found out
that each state provider already applied the sampling weight to each dataset before they were
combined into a single dataset for analysis. Also, we checked for the descriptive statistics, using
unweighted data for the descriptive and the crosstab, and we found that some variables have many
missing data that later render the regression model limited for analysis. We found that the
combined data yielded a total of 17,422 participants (NM=6,713; CT=10,709). A total of 795
(8.3%) female survey respondents said that they have been sexually abused in their lifetime. See
Table 4 for the summary.
According to the 2018 CDC weighting process, before weighting the data, a variable must
be created with the calculated individual weight (BRFSS, Behavioral risk factor surveillance
system questionnaire, 2019). In our case, each individual weight was already generated and
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provided to us by each public health department. The sampling weight variable was added to the
combined dataset and incorporated into the descriptive and regression analyses.
Furthermore, the missing data and small sample of female sexual violence victims for the
2018, which is the year of the data collection, made the analysis challenging. Some of the logistic
regressions analyses did not converge due to the low cell frequency issue on some variables in the
model resulting in some of the variables were dropped during the analysis.
Statistical Analysis
Unweighted frequencies and weighted percentage for selected major predictors and other
predictors characteristics of the entire adult sample (n=17,422) and crosstabulation of HPV and
Pap test participation across socio-demographic characteristics among female participants who
reported ever having sexual assaults in their lifetime (SEXWCREVISED) are summarized in
Table 2. Table 3 also presents crosstabulation of HPV and Pap test participation across sociodemographic characteristics among female participants who reported ever having sexual assaults
in the last 12 month, sampled among the lifetime population (WHSEXWCREVISED). General
sample characteristics are presented in Table 4 with unweighted total frequencies and column
frequencies and weighted row percentage for the entire population. P-values were obtained by the
second order Rao-Scott Chi-Square test for categorical variables.
We conducted the PROC SURVEYLOGISTIC procedure to examine the effect of sexual
violence history on cervical cancer screening participation outcomes of interest in 2 models. Table
5 summarizes results from each model on the outcome Pap, HPV and Pap/HPV tests. Model 1
examines the effect of lifetime history of sexual violence on cervical cancer screening and the
second model examines the effect of last 12-month history of sexual violence on cervical cancer
screening.
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We used SAS procedures for PROC SURVEYLOGISTIC to produce Adjusted Odds Ratio
(AOR), with 95% confidence intervals (CIs). The Taylor series linearization approach with
complex design features (i.e., strata, clusters, and sampling weights) provided by BRFSS survey
was employed for variance estimation (Heeringa, West, and Berglund, 2017).

Model Building Phase
It is worth mentioning that one of the major predictors “Sexual violence in the last 12
months” had the most missing cases; perhaps subjects have yet to cope with this terrible experience
and were not willing to mention it. In a first step, for each response variable, we subjected all the
candidate predictors to regression analysis. For each of the response variables, we looked at the
convergence notification and decided when to remove or add a predictor to conduct the regression
further. While doing the analysis in SAS, we were informed when a selected model was not fitted.
These were all signs that the fitting algorithm did not properly converge due to a quasi-separation.
In other words, a set of the predictor levels somewhat separated the “Yes” and “No” grouping of
the outcome variable. Although, this is purely a numerical problem it made the fitness of the model
inappropriate. The large standard error values indicated some instability. For this data set, this
problem occurred because 1) after removing the missing rows from the analysis the sample size
was small, and/or 2) some predictors had too many categorical levels with low cell frequencies in
some of these categories.
Refining the Selected Models
For a given response we selected the best possible according to the following three basic
criterions:
1) The fitting algorithm must fully converge without any separation (complete or quasi). For

quasi-separation, however, SAS issued some warnings to the user in some cases on models
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fit. For these reasons, we always examined the magnitude of the coefficient estimates,
corresponding standard errors, and estimated event probabilities to determine if the
algorithm had fully converged. When the convergence of the fitting algorithm was
satisfactory, we assessed the overall quality of the model using criterions 2) and 3)
described below.
2) We examined the models associated with significant lack-of-fit test p-values (p-value <
0.05) were excluded.
3) With models with one of the major predictors statistically non-significant (Females who
reported ‘Yes’ on WHSEXWCREVISED had relatively lower odds in HPV or Pap test
participation), we still decided to report the result of the analysis. The fact that
WHSEXWCREVISED sample is pulled from the SEXWCREVISED predictor also
reduced the sample size.
Ethical Considerations
This is a quantitative research study using only secondary data with a signed and approved
agreement from the data provider. The confidentiality of the agreement will be maintained within
the dissertation committee. According to The Claremont Graduate University Institutional Review
Board, this study qualifies as an exempt study, since the only involvement of human participants
will consist of research involving the collection or study of existing data and documents, with the
datasets publicly available and the information is recorded in such a manner that the participants
cannot be identified.
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DRPH Competencies

➔ DRPH-LM-1: Critically analyze an issue in health leadership, management, or policy and
provide recommendations: Health leadership and management can review alternatives that can
be used for gynecological exams to increase access to feminine care and improve rape survivors’
confidence in a medical procedure.

➔ FC-DRPH-18: Education & Workforce Development Assess an audience’s knowledge and
learning needs: Learning from sexual assault survivors can inform how an alternative to
gynecological exams can improve their confidence in undertaking the exam and whether using a
self-sample collection kit can make future sample collection procedures more comfortable.

➔ FC-DRPH-4 Leadership, Management & Governance Propose strategies for health
improvement and elimination of health inequities by organizing stakeholders, including
researchers, practitioners, community leaders, and other partners: From the results, we can
show how future adopted strategies can improve access to gynecological exams for vulnerable
populations, including rape survivors.

➔ FC-DRPH-5 Communicate public health science to diverse stakeholders, including
individuals at all levels of health literacy, for purposes of influencing behavior and policies:
Further investigations and programs’ implementations on how to improve specific medical
examinations might be developed or enhanced for a more beneficial application and bring change
to healthcare deliveries.
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CHAPTER 4: RESULTS

Descriptive Results
Table 1 shows the crosstabulation of HPV and Pap test participation by females reporting
a history of sexual abuse during their lifetime (8.3% of female participants). The table further
breaks down test participation by various socio-demographic variables, including age, education
proficiency, income, race, healthcare coverage, and attainment of a primary care physician.
Females aged 25 – 29 recorded the highest rates of HPV test participation (weighted row % =
82.1%), followed by females aged 30 – 65 (73.2%) and females aged 18 – 24 (57.8%).
Respondents aged 66 and above reporting a lifetime history of sexual assault were least likely
(40.0%) to seek out HPV testing. These age-related trends differed slightly for Pap testing; for this
type of cervical screening, 98.2% – 100% of participants reported seeking Pap testing for all age
groups outside of the 18 – 24 years group, which reported a participation rate of 61.9% seeking
Pap testing. Age group was a significant predictor of receipt of HPV testing (p<0.05) for those
reporting a lifetime history of assault. The Rao-Scott Chi-Square test was unable to yield a value
for Pap testing or Pap/HPV as 98.2% – 100% of participants within the age groups of 25 to 29 and
between 30 to 65 reported seeking Pap testing or Pap/HPV which resulted in almost no variations
of the responses across the cross-tabulated categories.
For those reporting a lifetime history of assault, women identifying as white were
significantly more likely to have received a PAP test (p<0.05) or Pap/HPV test (p<0.05) than nonwhite respondents, but not significantly more likely to have received only an HPV test (p-value =
0.970). Education status, income, health coverage, and acquisition of a personal doctor were not
associated with significant variation in test participation for this subset of participants.
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Like Table 1, Table 2 shows the crosstabulation of HPV and Pap test participation across
females reporting sexual assault within the past 12 months. Due to almost no variation of the
responses across the cross-tabulated categories, Rao-Scott Chi-Square tests failed to yield results
for test participation categorized by age group and income level and failed to yield marginally
significant results for education status (p-values = 0.121 – 0.451). The tests also failed to yield
values for Pap testing and HPV/Pap testing participation because of the low cell frequencies, and
HPV testing was not found to be significantly higher (p-value=0.998) in this group of participants.
Women self-identifying as white (77.1% of participants) were marginally significantly more likely
to report HPV test participation (p=0.058). For women reporting a recent history of assault, those
with a primary care physician were significantly (p<0.05) more likely to have obtained an HPV
test. Our analysis also shows a marginally significant (p-values=0.100) higher likelihood of
participating in Pap testing and Pap/HPV testing for women under the care of a primary care
physician.
With adjustment for other predictors, our models predict that females reporting ‘Yes’ on
SEXWCREVISED will exhibit lower odds of HPV testing participation than participants reporting
‘No’ (p<0.001) (Table 3). For participants in this group reporting ‘Yes’, age group and education
attainment (p-values<0.001) are significantly predicted to influence cervical screening
participation odds. The odds ratio results change for respondents reporting ‘Yes’ on
WHSEXWCREVISED, who are less likely to participate in cervical screening. The age group of
participants reporting ‘Yes’ is only marginally significant as a predictor of cervical screening
participation (p-value = 0.056).
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TABLE 1. Crosstabulation of HPV and Pap test participation across socio-demographic characteristics
among female participants who reported ever having sexual assaults in lifetime (SEXWCREVISED).
Major
Characteristics

HPV TEST

Pap TEST

Pap/HPV Test

P-value

Sample state
CT
NM

151 (68.6)
215 (68.4)

337 (92.8)
427 (94.2)

340 (93.2)
430 (94.9)

HPV test P = .000
Pap test P = .976
Pap/HPV test P = .592

17 (57.8)
23 (82.1)
279 (73.2)
43 (40.0)

20 (61.9)
33 (100)
523 (98.9)
175 (98.2)

23 (63.5)
33 (100)
525 (99.0)
176 (99.5)

295 (67.3)
70 (72.3)

616 (92.2)
146 (96.0)

620 (67.4)
148 (92.6)

HPV test P = .512
Pap test P = .206
Pap/HPV test P = .159

Income level
Less $75,000
$75,000 and up.

217 (69.2)
117 (73.8)

462 (94.7)
220 (96.5)

465 (95.0)
222 (96.9)

HPV test P = .475
Pap test P = .498
Pap/HPV test P = .471

Health coverage
Yes
No

343 (69.7)
22 (54.1)

725 (95.2)
38 (69.5)

731 (95.8)
38 (69.6)

HPV test P = .364
Pap test P = .190
Pap/HPV test P = .183

Personal doctor
Yes
No

309 (69.3)
57 (65.1)

657 (93.9)
107 (90.5)

662 (94.4)
108 (90.7)

HPV test P = .613
Pap test P = .447
Pap/HPV test P = .401

243 (68.1)
119 (67.8)

561 (96.9)
197 (85.6)

565 (96.9)
199 (87.0)

HPV test P = .970
Pap test P = .035
Pap/HPV test P = .058

Age group
18-24
25-29
30-65
66 and above
Education
Attainment
Yes
No

White (Race)
Yes
No

HPV test P = .032
Pap test P = *
Pap/HPV test P = *

Note: Surveyed 17,422 participants (NM=6,713; CT=10,709). 795 (8.3%) female participants have been sexually abused in their lifetime.
Unweighted Frequency (Weighted row %) Rao-Scott Chi-Square. CROSSTAB SEXWCREVISED*predictors*Cervical screening test.
* No Rao-Scott Chi-Square Test yielded because of low cell frequencies.
** No value.
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TABLE 2. Crosstabulation of HPV and Pap test participation across socio-demographic characteristics
among female participants who reported ever having sexual assaults in the last 12 month among the
lifetime population (WHSEXWCREVISED).
Characteristics

HPV TEST

Pap TEST

Pap/HPV Test

P-value

Sample state
CT
NM

3 (82.5)
11 (42.7)

9 (98.1)
15 (67.7)

9 (98.1)
15 (67.7)

HPV test P = .045
Pap test = .022
Pap/HPV test P = .022

2 (65.3)
**
11 (63.9)
1 (100)

3 (75.9)
1 (100)
19 (97.3)
1 (100)

3 (75.9)
1 (100)
19 (97.3)
1 (100)

8 (52.9)
6 (70.3)

14 (71.1)
10 (92.9)

14 (71.1)
10 (92.9)

HPV test P = .451
Pap test P = .121
Pap/HPV test P = .121

Income level
Less $75,000
$75,000 and up.

11 (45.9)
2 (100)

19 (89.5)
3 (100)

19 (89.5)
3 (100)

HPV test P = *
Pap test P = *
Pap/HPV test P = *

Health coverage
Yes
No

10 (64.9)
4 (64.9)

18 (100)
6 (100)

18 (83.9)
6 (100)

HPV test P = .998
Pap test P = *
Pap/HPV test P = *

Personal doctor
Yes
No

10 (78.3)
4 (24.2)

17 (93.5)
7 (60.3)

17 (93.4)
7 (60.3)

HPV P = .022
Pap test P = .100
Pap/HPV test P = .100

8 (77.1)
6 (36.5)

15 (93.4)
9 (66.8)

15 (93.4)
9 (66.8)

HPV test P = .058
Pap test P = .111
Pap/HPV test P = .111

Age group
18-24
25-29
30-65
66 and above
Education
attainment
Yes
No

White (Race)
Yes
No

HPV test P = *
Pap test P = *
Pap/HPV test P = *

Note: Surveyed 17,422 participants (NM=6,713; CT=10,709). 795 (8.3%) female participants have been sexually abused in their lifetime.
Unweighted Frequency (Weighted row %) Rao-Scott Chi-Square. CROSSTAB SEXWCREVISED*predictors*Cervical screening test.
* No Rao-Scott Chi-Square Test yielded because of low cell frequencies.
** No value.
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TABLE 3. General Sample Characteristics. Surveyed 17,422 participants (NM=6,713; CT=10,709).
Major
Characteristics
State
CT
NM
Age group
18-24
25-29
30-65
66 and above
Education
attainment
Yes
No
Income level
Less $75,000
$75,000 and up.
Health
coverage
Yes
No
Personal
doctor
Yes
No
White (Race)
Yes
No

Overall

SV=Yes

SV=No

p-value

12 month
SV=Yes

12 month
SV=No

p-value

5402
6713

396 (8.7)
502 (8.2)

4248 (91.3)
5253 (91.8)

.518

16 (6.8)
22 (6.8)

380 (93.3)
480 (93.2)

.971

603
492
6750
4019

51 (11.3)
40 (9.5)
601 (9.5)
192 (4.0)

437 (88.7)
351 (90.5)
5170 (90.5)
3380 (95.9)

.000

11 (22.7)
1 (1.7)
25 (4.4)
1 (0.2)

40 (77.3)
39 (98.3)
576 (95.6)
191 (99.8)

.056

7893
4179

710 (10.1)
185 (5.9)

6187 (89.9)
3285 (94.0)

<.000

24 (4.1)
14 (13.9)

686 (95.9)
171 (86.0)

.111

6586
3566

544 (8.9)
249 (7.8)

5183 (91.0)
2967 (92.2)

.202

25 (6.3)
4 (6.4)

519 (93.7)
245 (93.6)

.975

11319
762

848 (8.6)
49 (7.9)

8903 (91.4)
577 (92.0)

.774

31 (6.8)
7 (6.1)

817 (93.2)
42 (93.9)

.849

9906
2187

765 (8.8)
133 (7.7)

7820 (91.2)
1663 (92.3)

.387

25 (6.3)
13 (8.6)

740 (93.7)
120 (91.4)

.518

7665
4151

633 (9.2)
256 (7.6)

6127 (90.8)
3170 (92.4)

.102

22 (6.7)
16 (6.9)

611 (93.3)
240 (93.0)

.945

HPV TEST
2056
366 (19.4)
1532 (80.6)
14 (5.6)
352 (94.4)
Yes
<.000
.812
2608
220 (9.2)
2157 (90.8)
11 (6.7)
209 (93.4)
No
Pap TEST
5871
764 (14.4)
4644 (85.6)
24 (4.8)
740 (95.2)
Yes
.217
.246
383
28 (10.6)
306 (89.4)
6 (11.4)
22 (88.6)
No
Pap/HPV test
5897
770 (14.5)
4661 (85.5)
24 (4.7)
746 (95.3)
Yes
.159
.216
374
24 (10.1)
303 (89.9)
6 (12.3)
18 (87.7)
No
Note: Surveyed 17,422 participants (NM=6,713; CT=10,709). 795 (8.3%) female participants have been sexually abused in
their lifetime.
Unweighted Frequency (Weighted row %) Rao-Scott Chi-Square.

Table 4 shows the adjusted odds ratios (AOR), along with their significance and
uncertainty bounds, for predicted association between reported sexual assault and cervical
screening participation. Female participants who reported a lifetime history of sexual violence are
significantly (p<0.001) more likely (AOR = 2.08, CI = 1.46 – 2.95) to receive HPV test cervical
screening compared to participants who did not report past sexual assault. We also found that
women who reported sexual violence in their lifetime were twice as likely (p-value = 0.036) to
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participate in Pap testing (AOR = 2.15, CI = 1.05 – 4.41), and when it comes to Pap/HPV testing,
the same group of women were twice as likely (p-value = 0.045) to take part in either one or both
types of cervical screening tests (AOR = 2.3, CI = 1.01 – 5.25). Sexual violence falls away as a
statistically significant predictor (p = 0.818) of HPV test participation when respondents were
subsetted to only include those reporting sexual violence within the past 12 months; in fact, women
reporting recent sexual assault are less likely to have receive cervical testing than those not
reporting recent assault (AOR = 0.84, CI = 0.19 – 3.60).
Our models predict that education attainment is a significant predictor for cervical
screening for participants with a recent and lifetime history of sexual violence; participants without
a college degree reporting a more recent history of violence are predicted to be 4 times as likely
(AOR = 4.18, CI = 1.14 – 15.2) to receive Pap/HPV and to receive Pap testing (AOR = 3.39, CI =
1.03 – 11.1) than those with college-level education attainment. This predictor changes when
applied to those participants with a lifetime history of sexual assault; here, those with no college
attainment of education are less likely to have received Pap/HPV screening (AOR = 0.62, CI =
0.41 – 0.95).
Self-identification as white follows a similar pattern as education attainment in predicting
cervical screening participation. Our models predict that participants with a recent history of sexual
assault were having significantly (p=0.004) greater odds (AOR = 7.74, CI = 1.88 – 31.7) of
receiving Pap testing compared to the expanded group of participants reporting a lifetime history
of assault (AOR = 0.57, CI = 0.37 – 0.88; p=0.012). White women reporting recent sexual assault
were having significantly (p-value=0.009) lower odds to receive Pap/HPV testing (AOR = 0.22,
CI = 0.07 – 0.69) than non-white women reporting recent assault.
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For women reporting recent sexual violence, attainment of health coverage was found to
be a significant (p-values = 0.002 – 0.003) predictor of receipt of Pap testing and Pap/HPV testing.
Those reporting recent assault were more likely to have received combined HPV/Pap testing (AOR
= 9.01, CI = 2.13 – 38.0) if they reported having health coverage, but less likely (AOR = 0.20, CI
= 0.06 – 0.59) to have received only Pap testing, than those without health coverage.
For participants reporting a lifetime history of sexual violence, our model identified age
group as another significant predictor (p<0.001) of cervical screening participation, with
participants aged 25 – 29 years more than 5 times more to undergo an HPV test (AOR = 5.71, CI
= 3.07 – 10.6), more likely to receive a Pap test (AOR = 15.92, CI = 6.52 – 38.8), and more likely
to receive Pap/HPV testing (AOR = 13.34, CI = 5.75 – 30.94) than those in the 18 – 24 years
group. Participants aged 30 – 65 years were predicted to be over 3 times more likely to receive
HPV testing (AOR = 3.22, CI = 2.14 – 4.84). They were also more more likely to receive Pap
testing (AOR = 38.34, CI = 23.6 – 62.1), and to undergo Pap/HPV testing (AOR = 45.18, CI =
27.75 – 73.55) than participants in the 18 – 24 years age group. Participants aged 66 years or older
were more likely to undergo Pap testing (AOR = 16.73, CI = 10.3 – 27.1) or Pap/HPV testing
(AOR = 20.22, CI = 12.85 – 31.83) compared to participants aged 18 – 24 years, but only about
half as likely (AOR = 0.53, CI = 0.34 – 0.83) to receive HPV testing. We must restate that due to
the low cell frequency issue of the variables included in the models, results with the observed large
odds ratios were not reliable and should be interpreted cautiously.
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TABLE 4. Predicting association between sexual violence and participating in cervical screening using
multivariable logistic regression.
Surveyed 17,422 participants (NM=6,713; CT=10,709).
Outcomes

HPV TEST

Pap TEST

Pap/HPV TEST

Major Characteristics

Adjusted
Odds Ratio
(95% CI)

P-value

Adjusted
Odds Ratio
(95% CI)

P-value

Adjusted
Odds Ratio
(95% CI)

P-value

Sexual violence in the last 12
month

0.84 (0.19-3.60)

0.818

0.23 (0.04-1.10)

.065

0.19 (0.03-0.98)

.047

Health coverage
Yes Vs No

-

-

0.20 (0.06-0.59)

.003

9.01 (2.13-38.0)

.002

Education attainment
No-college vs College

-

-

3.39 (1.03-11.1)

.043

4.18 (1.14-15.2)

.030

White Vs Non-White

-

-

7.74 (1.88-31.7)

.004

0.22 (0.07-0.69)

.009

Sexual violence in lifetime

2.08 (1.46-2.95)

<.000

2.15 (1.05-4.41)

.036

2.31 (1.01-5.25)

.045

Age group

<.000

<.000

<.000

25-29 yrs old vs.
18-24 yrs old

5.71 (3.07-10-6)

15.92 (6.52-38.8)

13.34 (5.75-30.94)

30-65 yrs old vs.
18-24 yrs old

3.22 (2.14-4.84)

38.34 (23.6-62.1)

45.18 (27.75-73.55)

66 yrs or older vs.
18-24 yrs old

0.53 (0.34-0.83)

16.73 (10.3-27.1)

20.22 (12.85-31.83)

White Vs Non-White

-

-

0.57 (0.37-0.88)

Education attainment
No College vs College

.012

-

-

0.62 (0.41-0.95)

.028

Note: Major predicting variables in the logistic regressions are sexual violence (SEXWCREVISED) and last 12 month sexual
violence (WHSEXWCREVISED) (sexual violence and last 12 month sexual violence “No” is the reference group). Other
predictors (categorical) controlled in the logistic regression models are education, White (Race), coverage, personal doctor,
income, and age. However, only displayed in the table are the predictors that fit the models and were at some point statistically
significant. Those large odds ratios and wide confidence intervals were due to low cell
frequencies.
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CHAPTER 5: INTERPRETATION AND SUMMARY
It is critical to include innovative approaches to public health programs dissemination and
to increase access to preventive programs to vulnerable populations. Hard to reach populations are
part of the group of people who lack access to public health programs designed to improve their
access to care, but who also might find it harder to participate in certain programs such as cancer
screenings because of past dolorous experiences that might prevent them from taking part in
receiving healthcare delivery.
This study was critical in exploring one of the vulnerable populations, the sexual violence
victims, and their willingness to participate in cancer screening such as Pap and HPV testing.
Studies found that vulnerable communities (e.g., minorities, immigrants, transmasculine) were
already facing limited participation in cervical screening and those studies found that using an
alternative to the standard cervical screening was well appreciated and willingness to participate
was observed among the participants. One missing vulnerable group is the female rape victims,
who while they might be facing barriers that prevent them from getting screened for the HPV virus,
on top of that, are dealing with a history of sexual assault trauma, and there is a need to assess the
willingness of those women to get tested, as well as to assess their perception of using a selfcollected kit and the impact it can have on their decision to get routinely screened for cervical
cancer.
This study was designed to assess rape victims’ participation in cervical screening. We aim
to fill a research gap by addressing a few different aspects integrated within the explorative nature
of our study by also examining self-collection kit acceptability among the sexual violence
vulnerable groups, and their participation in cervical screening both Pap and HPV. Since the initial
goal is to assess the rape victim’s participation to HPV and Pap tests, we decided that using a
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secondary data was the most appropriate source of data. While searching for resources, we only
found the BRFSS national survey which comprises the same the variables of interest on
demographic, cervical cancer screening and sexual violence. Doing a multi regression analysis is
great for conducting a hypothesis testing and for an explorative study like this one.
As stated at the beginning of this study, the problem was that sexual assault is a traumatic
event that can affect sexual assault victims’ mindsets and influence their everyday decision making
(Chivers-Wilson, 2006). Because of past trauma, rape victims often find themselves feeling
vulnerable in situations like cervical screening, that they deem too invasive or reminiscent of an
abuse experience (Farid, 2019). The purpose of this study was to identify whether a sexual assault
might impact a female victim’s willingness to undergo a gynecological examination which
includes Pap and HPV testing. Associations between history of sexual assault and female victim
level of participation in routine cervical screenings were also examined. The central research
question was to know if, rape victims’ experience of abuse impacts their decision-making process
regarding getting routine cervical cancer screening, and the main issue being researched was to
know if experience with past trauma related to sexual violence has an impact in their decision to
get a Pap test or HPV test.
Summary of Findings
From the literature review, we found another study that used BRFSS data to conduct their
analyses. The study used the BRFSS 2006, with survey from 11 states and 1 territory that have
included the sexual violence module (Watson-Johnson, Townsend, Basile, & Richardson, 2012).
This is the ﬁrst multistate population-based study to examine the association between self-reported
sexual violence history and adherence to screening recommendations for breast and cervical cancer
(Watson-Johnson, Townsend, Basile, & Richardson, 2012). Of all respondents reporting a history
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of sexual violence, 75.7% were women (Watson-Johnson, Townsend, Basile, & Richardson,
2012). For the study, they used four questions which they considered to be the deﬁnition of sexual
violence, meaning that respondents who answered yes to any of the following questions (WatsonJohnson, Townsend, Basile, & Richardson, 2012):
1. Unwanted touching of sexual parts of the body within the past 12 months
2. Exposure to unwanted sexual situations that did not involve physical touching within the
past 12 months
3. Unwanted sex at any time in their lives,
4. Or ever experiencing attempted unwanted sex.
Then, the study examined the relationship between history of sexual violence and being up-to-date
with a Pap test for cervical cancer within the previous 3 years among women aged ≥18 years, based
on the USPSTF (Watson-Johnson, Townsend, Basile, & Richardson, 2012).
For the other study, which only focused on the PAP test, the dependent variables were
comprised of measures of current compliance with cancer and lifetime screening based on 2014
screening recommendations by USPSTF (Alcalá, Keim-Malpass, & Mitchell, 2018). The Kansas
2014 survey respondents were coded as victim of sexual violence if they answered “Yes” to the
following questions asked:
1. If they had ever received a particular screening procedure and then asked to indicate the
number of years since they had received the procedure to determine if they were currently
compliant with screening recommendations
2. If they ever had sex with you after you said or showed that you didn’t want them to or
without consent?” (Unwanted sex included “putting anything into your vagina [if
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female], anus, or mouth or making you do these things to them after you said or showed
that you didn’t want to” and included being unable to consent for any reason.
Further, compared to the previous studies using BRFSS, we wanted to explore the
association between sexual assault that occurred in their lifetime with each of cervical screening
Pap and HPV, and Pap/HPV. Our results after conducting the logistic regressions allow us to
identify key information and to compare how participation in the Pap or HPV exam can be
explored and understood. We used three different models to grasp all the information that can
enable us to summarize our data and to test our hypothesis. With our main predictors at this point
which are ‘lifetime sexual violence (SEXWCREVISED) and ‘last 12-month sexual violence
(WHSEXWCREVISED), we were able to observe critical differences between those who reported
having been a sexual violence victim in their lifetime, and different levels of age and income.
Because the survey was weighted to be representative of the adult population of Connecticut and
New Mexico, demographic characteristics are consistent with the study population.

Pap Testing and Sexual Violence
Our results have indicated that women who experienced sexual violence in their lifetime
are approximately 2.5 times more likely to do the Pap test than women who did not experience
sexual violence, meaning that the data provides strong evidence that lack of participation in Pap
test might be associated with effect of sexual violence on victims’ decisions to participate to
cervical screening. From this result, we found out that sexual victim’s status does not adversely
impact their decisions to get the Pap test, instead, they seem to be more willing to get screened
than women who did not experience sexual assault. This result can be compared to Alcala’s BRFSS
study who found that victims of sexual assault in their lifetime sexual assault was not associated
with odds of Pap test at 95% CI and suggested that the sexual assault had a negative impact on
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current compliance- but not with the pattern for lifetime screening with higher odds of screening
for some cancer screening which includes the Pap test (Alcalá, Keim-Malpass, & Mitchell, 2018).
We also found that among sexual violence that happened the last 12 months, the participant
had a 77% lower likelihood to get a Pap test even though it was not statistically significant, but
education, health coverage and race were significant. We might suggest that the more recent a
sexual assault is, it might make it more challenging for the victim to seek cervical screening when
time is due for the recommended screening. We can also suggest that maybe the last 12 months
does not correspond to the due time for the Pap test as recommended by the USPTF which might
explain the lower participation likelihood. Further, Alcala’s study also found that even if odds of
lifetime cancer screening for Pap were not associated with odds of Pap test, odds of lifetime cancer
screening for cervical cancers increasing age was associated with higher odds of cancer screening
(Alcalá, Keim-Malpass, & Mitchell, 2018), which seems to be similar to our results showing that
although lifetime sexual assault victims are more willing to get Pap testing, we found that the
group of women aged between 30 to 65 years old were the most likely to get Pap testing (AOR =
38.34) compared to women aged between 18 to 24 age old. However, this might be explained by
the USPTF guidelines, that recommended in 2018 that women aged between 25 to 65 to get Pap
testing every 3 years (NCI Staff, 2020).
Another study found no signiﬁcant differences in cervical cancer screening test use
between sexual assault victims and non-victims (Watson-Johnson, Townsend, Basile, &
Richardson, 2012). Instead, the study found that women who reported sexual assault victims were
slightly more likely to be up to date with the Pap test compared to nonvictims (85.6% vs. 84.3%,
respectively). Compared to Alcala’s study who examined the association between sexual assault
victims aged 21 years and above and current versus lifetime cervical screenings, Watson-Johnson
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examined the association between sexual assault victims and being up to date with the Pap test for
cervical cancer within the previous 3 years among women aged at least 18 years (Watson-Johnson,
Townsend, Basile, & Richardson, 2012). Watson-Johnson explained that women who have
experienced sexual violence undergo a sexual assault forensic examination immediately making
Pap tests a part of their personal health maintenance (Watson-Johnson, Townsend, Basile, &
Richardson, 2012). However, our results suggest that lifetime sexual assault victims are more
likely to get screened for Pap test controlling for age and education.
Alcala across his study models identified education as the most consistent predictor of
cancer screening (Alcalá, Keim-Malpass, & Mitchell, 2018) and indicated higher educational
attainment was associated with higher odds of lifetime cancer screening and current compliance
with cancer screening guidelines. In our case, education is also statistically significant and
associated with lifetime and last 12-month sexual violence and Pap and Pap/HPV. Our results also
indicated that in lifetime sexual violence, no-college women had a 38% lower likelihood to get
Pap/HPV testing, but also indicated that with the last 12-month sexual violence, education is also
associated with no-college attainment and a higher likelihood to get Pap and Pap/HPV testing. Our
results indicate that long-term compliance might be associated with education on preventive care
and that current compliance likely observed with the last 12-month sexual violence group may
correspond to an initial exam that might have happened after the sexual assault occurred.

HPV Testing and Sexual Violence
None of the previous studies that addresses sexual assault victims using BRFSS and
cervical screening participations explore the HPV screening test. In our study, controlling for age
only, we found that women who did experience lifetime sexual violence are approximately 2 times
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more likely to do an HPV test than women who did not experience sexual violence, meaning the
data provides strong evidence that lack of participation in HPV testing is less prevalent among
women who have experienced sexual violence compared to women who did not experience sexual
violence. Checking for the controlling variable, we found out the results provide strong evidence
that participation in HPV testing is more prevalent among women between ages 25 to 29 and 30
to 65. The results of the population aged between 25 to 65 corroborate the 2018 cervical screening
guidelines that required women in that age group to get tested for HPV alone or jointly with Pap
every 5 years (NCI Staff, 2020). Additionally, women aged between 30 to 65 and those aged
between 18 to 24 in 2018 were recommended to get HPV test every 5 years, or HPV/Pap cotest
every 5 years (NCI Staff, 2020). The age group between 18 to 21 and 65 and older were not
required to get tested for either HPV or Pap, especially if prior test were normal (NCI Staff, 2020)
which might explain why these groups of age are less likely to get screened than the other age
groups.

Cervical Cancer and Sexual Violence
The third model was used to explore the association between sexual assault and cervical
cancer screening consisted of age, education, race, and health coverage. Based on previous studies
that have used the BRFSS dataset and the sexual violence module, one of them was able to get a
larger sample (2006 BRFSS survey) that was conducted on 11 states and 1 territory, while the
second study used an only a BRFSS data from one state (Watson-Johnson, Townsend, Basile, &
Richardson, 2012) but used a gender inclusive approach and conducted analysis on multiple cancer
screening tests (mammogram, Pap, prostate, Pap test).
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Discussion
This study advances the research on participations to cervical screening for cervical cancer
prevention by performing data analysis that comes to add on previous studies that have assessed
the relationship between history of sexual assault with unconsented penetration and participation
in Pap/HPV screening tests. Pap along with HPV testing are both screening approaches that can
be used by itself or together to collect specimens that can identify cells responsible for cervical
cancer. By using both tests, we can assess participation in either one of the tests, both tests, which
tests was the most taken, and if neither of both tests were undergone. The second test that explored
the relationship between the sexual violence victims and their participations in cervical screening
mentioned further study on looking at the direct effect of health plan coverage- we added this
component in our study to advance the field, in addition to the effect of having a personal doctor,
age, and race. We were interested in examining access to a health plan because cervical screening
is covered by any health coverage including both Medi-Cal and Medicaid as a preventive women
care measures. However, from the analysis, it was a predictor that only explained last 12-month
sexual victims’ participation to HPV testing and was not part of the rest of the models. We decided
to look at other predictors’ effect and since we considered that having a health plan coverage and
at least one personal doctor might influence participation in Pap/HPV test, both factors were
instead dropped from most of the models during the analysis as they ultimately were not relevant
to our study’s approach.
Following the CDC guidelines (New ACS Cervical Cancer Screening Guideline - National
Cancer Institute, n.d.) indicating when a woman should get screened, we were wondering if being
covered and having access to a personal doctor will impact sexual assault victims but found
otherwise that health coverage was dropped from all of our analysis. Our first alternative
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hypothesis states that there is a statistically significant relationship between an individual being a
victim of sexual violence (rape) and getting routine cervical cancer screening (Pap and/or HPV)
and we found that sexual assault victims were more likely to get tested than women who have not
experienced rape, indicating that sexual assault impacts the victim’s participation to cervical
screenings. This is critical because it indicates that indeed trauma-related sexual assault positively
impacts the victims to get tested for cervical cancer.
Looking further, we wanted to understand access to cervical screening to find if the HPV
and the Pap tests were available to those who wanted to get tested whether they have health
coverage and if not, if they had the opportunity to get tested through a third party for women with
limited financial means. For Medicare, we found that as part of the pelvic exam, Medicare covers
a clinical breast exam to check for breast cancer. Medicare part B covers Pap tests and pelvic
exams to check for cervical and vaginal cancers and if one is at a high risk for cervical or vaginal
cancer, or of child-bearing age and had an abnormal Pap test in the past 36 months, Medicare
covers these screening tests once every 12 months (Cervical Cancer Screening Coverage, n.d.).
Medicare Part B also covers Human Papillomavirus (HPV) tests (as part of a Pap test) once every
5 years if aged 30-65 without HPV symptoms (Cervical Cancer Screening Coverage, n.d.).
Furthermore, there is no pay required for the lab Pap test, the lab HPV with Pap test, the Pap test
specimen collection, and the pelvic and breast exams if one’s doctor or other qualified healthcare
provider has an agreement to be paid directly by Medicare (Cervical Cancer Screening Coverage,
n.d.). However, to be eligible Medicare, an individual must be entitled to receive benefit based on
their own earnings or those of a spouse, parent, or child (CMS, 2021), which are quarters of
coverage earned through payment of payroll taxes under the Federal Insurance Contributions Act
(FICA) during the person's working years (CMS, 2021). It may happen that your doctor or other
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health care provider recommends to get services more often than Medicare covers and if this
happens, out of pocket payment may be requested for some or all of the costs (Cervical Cancer
Screening Coverage, n.d.).
Also, through Connecticut Medicaid, the Connecticut Early Detection and Prevention
Program (CEDPP): Breast and Cervical Cancer, offers free statewide screening program for early
detection of cervical cancer, a program for uninsured or underinsured low income women that
allows them to get tested for Pap only for women ages 21-64 (Connecticut Early Detection and
Prevention Program (CEDPP): Breast and Cervical Cancer - United Way of Connecticut - 211
and ELibrary - Health Care Payment Assistance/Health Insurance, Health Issues, n.d.).
Further, through the NBCCEDP, the CDC helps low-income, uninsured, and underinsured
women gain access to timely breast and cervical cancer screening, diagnostic, and treatment
services (Cervical Cancer Prevention and Screening: Financial Issues, n.d.). The cervical
screening though the program, is administered within each state and the Centers for Disease
Control and Prevention (CDC) provides support to each state program and includes both Pap and
HPV tests (Cervical Cancer Prevention and Screening: Financial Issues, n.d.).
Moreover, coverage of cervical cancer screening tests is mandated by the Affordable Care
Act (ACA) and if the insurance plan started on or after September 23, 2010, it is required to cover
the recommended cervical cancer screening tests which included both Pap and HPV (Cervical
Cancer Prevention and Screening: Financial Issues, n.d.). Even the self-insured (or self-funded)
plans that pay employee health care costs from their own funds, these plans are governed by the
Affordable Care Act (ACA), so most are required to cover cervical cancer screening (Cervical
Cancer Prevention and Screening: Financial Issues, n.d.). We can also explain the difference in
getting Pap and HPV test by remembering that the 2018 cervical screening guidelines

68

recommendations were to get Pap test only every 3 years for those aged between 21 to 29 years,
and only recommended HPV test starting at age 30 to 65 every 5 years, or in co-test with Pap every
5 years (New ACS Cervical Cancer Screening Guideline - National Cancer Institute, n.d.).
Limitations
This study was conducted using datasets that were provided by the public health
departments that have agreed to let us have access to the survey's responses. We were able to have
access to two datasets from Connecticut and from New Mexico. To improve the dataset’s
representativeness, we decided to merge both datasets. Also, to increase frequencies, we
considered the weight added to each participant and already computed by each state. However,
working only on two datasets, and focusing on a limited target population which are the sexual
assault victims, and dealing with the missing values, we must discuss some factors that might have
contributed to this study’s limitations.
One of the limitations we dealt with was the small target population sample. Because of
the small sample, we ended with some logistic regression analysis that did not converge. The
model summaries will indicate that iteration has been reached and that final solution cannot be
reached. During the analysis, we eliminated some controlling variables such as plan coverage and
having access to a personal doctor. Not being able to complete an analysis that could have provided
us with a deeper understanding on the victim’s participation in cervical screening and help us to
explore the effect of having medical insurance coverage and access to a personal doctor during the
decision of getting tested for Pap/HPV tests. Representativeness is one limitation that arises
because the BRFSS survey only surveys a part of the population in each state per year. We are
only using two surveys, which are from the states of New Mexico and Connecticut and those
surveyed are limited to only residents who had landline telephones. BRFSS surveys are cross69

sectional in nature hence, we are unable to determine the causal relationship between rape victims
and the use of cervical screening tests. Another limitation is that, per the results, they have
indicated that sexual assault victims are mostly willing to participate in cervical cancer screeningbut because this study is based on a national survey, we are lacking deep information on what
makes them willing to participate in the Pap and HPV test. We do not know what factors
contribute to their participation in an exam that have been proven by other studies to be reminiscent
of past trauma, and therefore, prevents them from participating in the Pap/HPV test. Further,
temporality is one of the limitations that pertains to our study. Not knowing when exactly the
sexual violence occurred and when the cervical screening took place limits our study approach. It
makes it challenging to understand if not getting test either for Pap or HPV is a result of history of
sexual violence or just following guidelines to cervical screening recommendations and waiting
time.
However, for this study, the methodology which consisted of combining the dataset to
improve the sample size of our populations of interest and adding weight helped to increase each
variable frequency and increased the reliability and validity of our results. Working with a small
sample size and willing to generalize the results, our approach was the most appropriate and in
conformity with the CDC BRFSS’ survey analysis.
Recommendations and Future Directions
Many studies have used either quantitative or qualitative approaches to assess if vulnerable
populations were presented with an alternative to the standard, but still found gap in the literatures
that indicates that more can still be done to improve access to those who suffer from trauma-related
sexual violence with forced physical penetration. No profound assessment on the sexual assault
victims and their utilization of alternative cervical screenings were ever conducted. The alternative
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in this case is the utilization of a self-collected sampling in lieu of using a clinician assisted cervical
screening. There has been no in-depth information on how using a self-collection impacts their
confidence, their willingness to undergo cervical screening, and the differences that they believe
may or may not influence their choice to get screened without any medical professional assistance.
So far, studies have explored the willingness to use self-collected HPV kit among vulnerable
populations such as the transmasculine community, the immigrant population, minorities and the
low income groups, but when it comes to rape victims, studies have reviewed data such as the
national survey BRFSS from different years (Alcalá, Keim-Malpass, & Mitchell, 2018; WatsonJohnson, Townsend, Basile, & Richardson, 2012), and have recommended that use of alternatives
to cervical screenings should be beneficial to raise cervical screening uptakes, but also to allow
women with fear and trust issues to be willing to participate in routine cervical screening.
There are multiple key recommendations we can make: partnering with rape victims
directly to obtain further insight to inform and improve research, using mixed methods to
strengthen information gathering and permits researchers to understand how a self-kit impacts rape
victims, and finally, to design policies and expand the field of study to not only explore selfcollection kits but also examine access, utilization, education, and acceptability.
The first recommendation will be to hear from the female rape victims firsthand and receive
insightful information. This study relies on secondary data BRFSS which is the only national data
where we can find questionnaires on the demographics, the cervical cancer screenings, and
questions on sexual violence. Further studies on rape victims and cervical screening participations
should consider doing qualitative studies. Doing focus groups or performing interviews are great
approaches to research that can yield perceptive information only available from rape victims.
With an interview, we will be able to know how they feel when using a self-collection kit versus
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the standard physician screening, and to know if this can have an impact on them participating in
the screening and importantly, why. The literature is lacking rape victims’ voices in what might
help them to take part to routine cervical screening and improvement that a kit might bring their
way in deciding which screening method they prefer and how it might affect their confidence in
routine screening participation.
The second recommendation will consist not only of conducting qualitative interviews or
focus groups, but also having further studies in mixed methods approaches. A mixed-method study
with both qualitative and quantitative sharing the same power, also called concurrent triangulation
design where results are used at the same time during the interpretation phase. A mixed method
might help to get information that a qualitative approach alone might not be able to explore, but
also enhances the studies’ generalizability. Using both a qualitative method, e.g., interviews, and
a quantitative method such as an experimental design with participants allocated to different
groups in an experiment. Using a mixed method will also provide tools to the researchers to
balance both methods' strengths and help outweigh the weaknesses that each method encompasses.
We should not forget that rape victims are among the vulnerable group that can be hard to reach
due to the protected status they benefit under federal and state laws and policies, but also because
of the history of trauma that might prevent them from feeling fully comfortable while participating
in a qualitative study, therefore, adding a quantitative approach can only help outweigh the
disadvantages that might come while interviewing or conducting focus groups with the sexual
violence participants. Using a mixed method will also help to resolve the issue of temporality,
history of rape and history of due date for a cervical screening depending on their due date based
on the USPTF recommendations. During interviews, researchers will be able to know when the
rape happened, how they were, and when was their last visit (if any) for their cervical screening
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and to know for those who have experience with the standard cervical screening if after a rape
their willingness to participate in routine screening was affected, and later measure the impact of
self-collected kit on the rape victim’s participation’s willingness. For this recommendation, a selfcollection kit should be made available to the participants. Previous studies that have
recommended using an HPV self-collecting device also have proposed using the latest kit which
they believe will bring the most comfort to women facing willingness issues to participate in
cervical screening. The literature indicates that a self-sample collection kit can reduce barriers that
vulnerable women might face such as fear, challenging socio-economic status, and stigma (Rocha
et Al., 2015). Further, different testing in different countries have indicated that self-sampling
gives women the opportunity to get tested for HPV who might not feel comfortable lying on a
table in a physician’s office (Mahomed et Al., 2014). Retraumatization is a barrier that can be
difficult to overcome for rape victims and was not cited in the literature as a barrier that a selfsampling kit can address. A self-collection can become an essential component/part of the
healthcare system, and further studies on sexual and reproductive health can empower individuals
and achieve public health goals to promote equitable and fearless access to care for women with
history of trauma (Women Who Have Option of Using HPV self-sampling Kits More Likely to
Seek Cervical Cancer Screening, New Analysis Finds| Department of International Health | Johns
Hopkins Bloomberg School of Public Health, n.d.).
Conducting future mixed method study including a self-sample kit will yield information
on how to improve access to cervical screening for women with history of rape but using a selfcollection kit recommended by the literature is highly recommended. One of the recommended
self-collected kits for HPV testing is one of the brushes made by the ROVERS Medical Devices,
a company based in the Netherlands. This company designs and manufactures cancer screening
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tools but also self-sampling devices. One of their brushes, the ‘Evalyn” brush is used and cited in
many studies across the world and has received a lot of attention from researchers especially in
related studies (Ejegod et al., 2018) and used for the HPV Self-Collection Pilot Study conducted
by Dr. Surendranath Shastri in Houston, Texas (Texas State HPV Self-Collection Pilot Study,
n.d.). The Evalyn brush is an innovative brush, contrary to its predecessors, a newly designed HPV
self-collected brush to ease its use for women and an easy, safe, and reliable method of collecting
vaginal/cervical specimens without discomfort. The brush features soft and flexible hairs that can
collect sufficient cell material, irrespective of the age or health of the woman concerned (Evalyn®
Brush - Rovers Medical Devices, n.d.). Some of the benefits of this brush are: built-in features to
assure correct sample taking, standardized method for taking samples results in the highest number
of valid samples across all age groups (one time right, no repeat sampling), and a comprehensive
solution for self-sampling collecting, shipping, and processing in the laboratory (Evalyn® Brush Rovers Medical Devices, n.d.). Also, one of the benefits is that each brush comes with a unique
RFID identification (Radio Frequency Identification) chip, equipped with a barcode to link each
sample to a woman’s ID securing the patient information (Evalyn® Brush - Rovers Medical
Devices, n.d.). The Evalyn brush have been used in previous studies that were studying HPV selfsampling acceptability among women living in rural areas in Africa (Brandt et al., 2019), the
applicability and accuracy among responder women population aged 30 to 60 years old (Ketelaars
et al., 2017), on a pilot cross-sectional study involving 116 women over 21 years of age with an
abnormal Pap smear (Lorenzi et al., 2019), and finally was also used for an online survey in Fall
2017 with a national sample of women in the United States (n = 605) ages 21-65 years where a
multivariable linear regression identified correlates of women's willingness to use an HPV selfsample at home (Bishop et al., 2019). Studies have indicated that while using the Evalyn brush for
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their study, future efforts should consider the potential impact that a device type may have on
women's use of an HPV self-sample. Future studies, using a mixed-method approach with an
experimental strand using an Evalyn brush will help explore willingness to participate in cervical
screening among those who suffered from trauma, specifically related to a sexual assault history
with forced penetration.
The third recommendation is to design policies and expand the field of study to examine
access, utilization, education, and acceptability. The recommendation is to assess if the conditions
under the sexual violence differently impacted rape victim’s willingness, and if a self-collection
kit can make an impact on the participation in cervical screening. In other words, further research
on how the rape occurs can yield deep information on how impactful a self-collection can be
effective or not. Thinking about women living in crisis environments such as civil conflicts
(religious, ethnic, clan) war and displaced or living in refugee camps, who might not only be
dealing with the trauma of a rape, but the difficult living conditions and the trauma that a civil
conflict can bring, studies assessing women living in this kind of situation and presented with an
alternative to get screened for gynecology women preventive screening might yield insightful
information that will be useful for the literature and for future recommendations on studies about
vulnerable populations and their participation to cervical screening. In other words, policies can
help to provides health care professionals to offer alternatives to patients who might present
barriers when seeking for routine cervical screening.
Conclusion
We compared our results to works of Watson-Johnson and Alcalá and found that sexual
assault that have occurred in the lifetime have an impact on the victim’s decision to participate in
cervical screening. Compared to the previous studies that explored sexual assault victims’
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participation, these women are more than willing to get screened for either cervical cancer test,
whether it is Pap or HPV. We hypothesized that because of their history of trauma and the fear of
retraumatization, sexual assault victims might not make the decision to participate in Pap/HPV
testing, but our statistical analysis results instead show that the sexual assault victims are more
likely to participate in Pap and HPV testing only if sexual violence occurred in their lifetime.
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